Journal of Rheumatology 2004: Vol 31 Table of Contents

2004·2.8 MB·English

Journal of Rheumatology, Volume 31, 2004
CONTENT INDEX Pages 1-2582 and Supplements 69-71
VOLUME 31: NO. 1 JANUARY 2004
Editorials Ethnic Differences in Cytotoxic T Lymphocyte Hydrocortisone and Deflazacort Induce Different
Defining Remission in RA: What Is It? Associated Antigen 4 Genotype Associations Effects on Vitamin D Receptor Level Increase
Does It Matter? H.E. Paulus.1 with SSc Produced by 1,25-Dihydroxyvitamin D3 in Rat
Pain Relief in Osteoarthritis: The Rationale for L.L. Hudson, R.M Silver, J.P Pandey.85 Osteoblast-like UMR-106 Cells
Combination Therapy R.D. Altman.5 Multiplex RT-PCR Assessment of Sialyltransferase R. Guerrero, C. de la Piedra, E. Teixeiro,
Are Individual Patient Trials (n-of-1 Trials) in Expression in Peripheral Blood Mononuclear R. Bragado, M L. Traba.167
Rheumatology Worth the Extra Effort? Cells in SSc Joint Laxity and the Benign Joint Hypermobility
PM. Petoso.8 D. Launay, J-P. Peyrat, A. Verdiere, etal.88 Syndrome in Student and Professional
RHh.e Au m. Baitrodl.ogical Aspects of Dance 12 EPrtiamnearryc eSpSt :i nA t hPeil oTt rSeatutmdye niVt fo.Mf. PZaatniednbetslt ,w ith BMal.l eMt cDCaonrcmearcsk , J. Briggs. A. Hakim, R. Grahame .173
New Insights into Prostaglandin Biology PC M. de Wilde. PA. van Damme, C.B. Hoyng. Pediatric Rheumatology
J. Martel-Pelletier. J-P. Pelletier, H. Fahmi.14 L. B.A. van de Pulte, F.H.J. van den Hoogen.96
The Role of Subcutaneous Administration of MTX in
Articles Takayasu's Arteritis: Vascular Interventions and Children with JIA Who Have Failed Oral MTX
Outcomes P. Liang. M. Tan-Ong, G.S. Holfman.102 K. Alsufyani, O. Ortiz-Alvarez, D A. Cabral,
HAHSiuug.m thoI waaDnnai ktaEiibg-rEonygdothaiswertoisac c,i ynVH tae.R l MAuCe aaD otlspefu atAnesoctn,at tetKiidcn. a bYlapysua d EsAotLhanI,tt SiiengAt ea Unl .sing 17 IwnOiftl.h ix OCinmhiaarnobkn Tiitcha neH,r aeCpp. yaD tfiutoivrso RBuxh o,e rDu C.m C ahtiacll iDnei,s eeatasel.s in Pati1en0t7s ACHLoeuBantorg. tie mTBnumlicotkaucelkn ra,:e nR ARd EP eP.os opPpseouttnlntyasa,te tiaoP il.nnNly .BM DMaosiataelhgldeen srSoost nsoue fdd .yC I hs1oilldartee7nd wi9th
TNF-a Production Is Associated with Less Body Expression of MMP and TIMP in Pigmented H. Julkunen, A. Miettinen, TK. Walle, E.K.L. Chan,
Cell Mass in Women with RA J. Walsmith, Villonodular Synovitis Suggests Their Potential M. Eronen.183
L. Abad, J. Kehayias, R. Roubenoff.23 Role for Joint Destruction
Arthritis in Mice: Allogeneic Pregnancy Protects M. Uchibori, Y. NishkJa, I. Tabata, etal.110 Case Report
More Than Syngeneic by Attenuating Cellular Fat Suppression MRI in Shoulders of Patients with Diabetic Muscle Infarction: Case Report
Immune Response D A. Gonzales. A.C. de Leon, PMR F. Cantini, C. Salvarani, L. NiccoH, etal.120 and Review
C.V. MonchoU, J.C.D. Cordova, LB. Hernandez.30 Radiological Scoring Methods in AS. Reliability S. Kapur, J.A. Brunet, R.J. McKendry.190
Enhanced CorKentrations of IL-16 Are Associated and Change over 1 and 2 Years
with Joint Destruction in Patients with RA A. Spoorenberg, K. de Vlam, Correspondence
L R. Lard, B.O. Roep, R.E.M. Toes, T.W.J. Huizinga. . 35
S. vanderLinden, etal.125 Economic Cost and Epidemiological
VDinaA RluSAe2 8o-f3 DCiosmeapsaer Aedc ttiovi AtyC SRc-oDreef 2in8e d(D RAeSm28is)s aionnd BOerihgpine tL’si vDinigse ians Ge einr mPaantiye:n Ats Coof mGpearmraatinv ea nAdn Taluyrskiiss h CRehpalrya cRt.e rRisotbicinss oonf .FM G.E. Ehrlich.119955
A. Balsa, L. Carmona, I. Gonzalez-Alvaro, etal.40 I. Kotter, R Vonthein, C.A. Muller, I. Gunaydin, Reply PL. Dobkin, S. Bernatsky.195
Participation in Paid and Unpaid Work by M. Zierhut, N. Stubiger .133 Letter
Adults with RA C.L. Backman, S.M. Kennedy, The Efficacy and Cost Effectiveness of N of 1
A. Chalmers, J. Singer.47 Studies with Diclofenac Compared to Standard An Unusually Complicated Case of Primary SS:
Comorbidity in Patients with RA: Effect on Health- Treatment with NSAID in OA Developnoent of Transient “Lupus-type"
RCel.Eat. eJda cQoubai,l iHty. Jo. fD Linifaen tI,. RGu.Ap.pM. .H v.Can. Bdeonsh Buiozse.n, 58 EJf.f iEc.a cPyo paen.d M S. aPferatysh okfe rT, rJa.m Aanddoelr/s Aonc.etaminophen 140 ARReu.jtAeoc.a tAniotsinhb eordsoiens, FY.o Sllhooweinnfge lSd,i lCic oBnoe sInmiapnl.ant 196
Ability of Foot Radiographs to Predict RA in Tablets (Ultracer) as Add-on Therapy for OA
Patients with Early Arthritis V. Devauchelle Pensec, Pain in Subjects Receiving a COX-2 NSAID: A Book Review
NAu. trSiaernatu Ixn,t aJk.Me .a ^nrdt hDeileott Q. eutaalilt.y in Patients 66 MPluaclteicbeon-tCero, nRtraonldleodm Tirzieadl , Double-Blind, Rheumatoid Arthritis.198
with SLE on a Culturally Sensitive Cholesterol R. Emkey N. Rosenthal, S-C. Wu. D. Jordan. Correction
Lowering Dietary Program M Kamin .150
M. Shah, B. Adams-Huet, A. Kavanaugh, OMERACT Rheumatoid Arthritis Magnetic
Y. Coyle, P. Lipsky.71 Risk Factors for Knee OA in Japanese Women: Resonance Imaging Studies. Core Set of MRI
N-Acetyl Transferase Genotypes in Relation to Heavy Weight, Previous Joint Injuries, and Acquisitions, Joint Pathology Definitions, and the
Risk of Developing SLE Occupational Activities OMERACT RA-MRI Scoring System
G.S. Cooper, E.L Treadwell, M.A. Dooley. N. Yoshimura, S. Nishioka, H. Kinoshila, etal.157 M. Ostergaard, C. Peterfy, P. Conaghan, etal..198
E.W. St.Clair, G.S. Gilkeson, J.A. Taylor .76 Etidronate Prevents High Dose Glucocorticoid
IL-1a Single-Nucleotide Polymorphism Induced Bone Loss in Premenopausal Individuals Notices.xi
Associated with SSc B. Huiyrova, J. Lukac, with Systemic Autoimmune Diseases
V. Bosak, M Buc, R.M. du Bois, M. Petrek.81 S. Nakayamada, Y. Okada, K. Saito, Y. Tanaka .... 163 Online Instructions.viii
VOLUME 31: NO. 2 FEBRUARY 2004
Editorials A Web-Compatible Instrument for Measuring Self- Autoimmune Response to Proteasome Activator
Reported Disease Activity in Arthritis 28a in Patients with Connective Tissue Diseases
Translating Research into Practice: Acetaminophen N. Athale, A. Sturley, S. Skoczen, A. Kavanaugh, M. Matsushita, Y. Takasaki, K. Takeuchi, H. Yamada,
in Osteoarthritis Revisited L Lened . 223 R. Matsudaira, H. Hashimoto.252
D.L. Scott. G. Kingsley.199
Patient Questionnaires and Formal Education Effects of Disease Activity, Pain, and Distress on
Rheumatological Creativity and Leflunomide Level as Prospective Predictors of Mortality Activity Limitations in Patients with SLE
J.M Kremer.203 Over 10 Years in 97% of 1416 Patients with RA C M. Greco, TE Rudy, S. Manzi .260
TUrtiilailtsy ABreey Sohnodr Ct, lDiniisceala sTer iLalosn g: Measuring Drug frJo. mK e1y5s oUr,S TP. rSiovkaktea ,P Er.a cKtriicsehsn anT, LPiFn cCuas,l lahan . . 229 MAa. cFrooopthea, gEe MM. iBgrriagtaionnti , InY.h Kibiipteonry, LF. aScatnotro isn, SLE
M E. Luggen .205 RA Treatment with Weekly Leflunomide: M. Leech, E.F Morand.268
An Open-Label Study J. Jaimes-Hemandez,
Articles MM ER. oDbalvesa-loSsa-nZ uRgoamslai,n ,S .R A. Srruoayroe-zB-Oortreergoo, .235 Canldo sSeL AEs sDoicaigantioosnis o: fC Haseerp-Ceso nZtoroslt eSr tRudeya cotifv Pataitoienn ts
TRACh ePe.pSo lE.pa fcuCfeleramoctwtie oosnnoft n OTB, rhaWaesle.r MaCdp. o SyOn ttou'Frndaa ycltle hopneM,t iR.SvFi.e.sE skD. aooGnrfaad Rnb ,rEA ies: lt rog.e..n 207 EMJPfMf AeCPc htaK wonlifidm eR ciTukeIkoMp,. eSPa. tienSd iPe rIaantkfiloeiwnxitsmsk iaw, biI t.T hD hRoeAmra ypsyla owns kSae, rum2 38 wDJMii.tsEh.oD . Sr. PdLLoeEarps seok .i rnA N.. oKnriiznofvlaam, Jm.Mat. oOryu iMmeut,s cJu.Llo. sGkoeoledtwailn 2, 74
Tof6h .eO TInnesfnelgut seatnrnacdne d Oo, fuM tS.c eoAxmh ioemn Ae nRf,tA eIr.: HA2 aYPlsretoraosrmsp e, ctive Study TEPrlfaeficacetambcoye naCtn oodnf tSRroaAlfl:ee tAdy RDofao nTsdeao-cFmroinilzidmeindug, s D S(FotuKudb5yl0e 6 B) ilnin d, TSOALrunaEttnci bosoovrm deLeiresu asep n uMds -yRleikelieltei sDv aainssec taehs eoe f:F AGirnostto idpM hFaonusinpfchetsoitolaintpiaiodln of
for the BARFOT Study Group.214 H. Kondo, T. Abe. H Hashimolo, etal .243 DP. D’Cruz, S. Mellor-Pita, B. Joven, etal.280
2572 The Journal of Rheiiniatoloffy 2004; 31:12
Journal of Rheumatology, Volume 31, 2004
CONTENT INDEX Pages 1-2582 and Supplements 69-71
VOLUME 31: NO. 1 JANUARY 2004
Editorials Ethnic Differences in Cytotoxic T Lymphocyte Hydrocortisone and Deflazacort Induce Different
Defining Remission in RA: What Is It? Associated Antigen 4 Genotype Associations Effects on Vitamin D Receptor Level Increase
Does It Matter? H.E. Paulus.1 with SSc Produced by 1,25-Dihydroxyvitamin D3 in Rat
Pain Relief in Osteoarthritis: The Rationale for L.L. Hudson, R.M Silver, J.P Pandey.85 Osteoblast-like UMR-106 Cells
Combination Therapy R.D. Altman.5 Multiplex RT-PCR Assessment of Sialyltransferase R. Guerrero, C. de la Piedra, E. Teixeiro,
Are Individual Patient Trials (n-of-1 Trials) in Expression in Peripheral Blood Mononuclear R. Bragado, M L. Traba.167
Rheumatology Worth the Extra Effort? Cells in SSc Joint Laxity and the Benign Joint Hypermobility
PM. Petoso.8 D. Launay, J-P. Peyrat, A. Verdiere, etal.88 Syndrome in Student and Professional
RHh.e Au m. Baitrodl.ogical Aspects of Dance 12 EPrtiamnearryc eSpSt :i nA t hPeil oTt rSeatutmdye niVt fo.Mf. PZaatniednbetslt ,w ith BMal.l eMt cDCaonrcmearcsk , J. Briggs. A. Hakim, R. Grahame .173
New Insights into Prostaglandin Biology PC M. de Wilde. PA. van Damme, C.B. Hoyng. Pediatric Rheumatology
J. Martel-Pelletier. J-P. Pelletier, H. Fahmi.14 L. B.A. van de Pulte, F.H.J. van den Hoogen.96
The Role of Subcutaneous Administration of MTX in
Articles Takayasu's Arteritis: Vascular Interventions and Children with JIA Who Have Failed Oral MTX
Outcomes P. Liang. M. Tan-Ong, G.S. Holfman.102 K. Alsufyani, O. Ortiz-Alvarez, D A. Cabral,
HAHSiuug.m thoI waaDnnai ktaEiibg-rEonygdothaiswertoisac c,i ynVH tae.R l MAuCe aaD otlspefu atAnesoctn,at tetKiidcn. a bYlapysua d EsAotLhanI,tt SiiengAt ea Unl .sing 17 IwnOiftl.h ix OCinmhiaarnobkn Tiitcha neH,r aeCpp. yaD tfiutoivrso RBuxh o,e rDu C.m C ahtiacll iDnei,s eeatasel.s in Pati1en0t7s ACHLoeuBantorg. tie mTBnumlicotkaucelkn ra,:e nR ARd EP eP.os opPpseouttnlntyasa,te tiaoP il.nnNly .BM DMaosiataelhgldeen srSoost nsoue fdd .yC I hs1oilldartee7nd wi9th
TNF-a Production Is Associated with Less Body Expression of MMP and TIMP in Pigmented H. Julkunen, A. Miettinen, TK. Walle, E.K.L. Chan,
Cell Mass in Women with RA J. Walsmith, Villonodular Synovitis Suggests Their Potential M. Eronen.183
L. Abad, J. Kehayias, R. Roubenoff.23 Role for Joint Destruction
Arthritis in Mice: Allogeneic Pregnancy Protects M. Uchibori, Y. NishkJa, I. Tabata, etal.110 Case Report
More Than Syngeneic by Attenuating Cellular Fat Suppression MRI in Shoulders of Patients with Diabetic Muscle Infarction: Case Report
Immune Response D A. Gonzales. A.C. de Leon, PMR F. Cantini, C. Salvarani, L. NiccoH, etal.120 and Review
C.V. MonchoU, J.C.D. Cordova, LB. Hernandez.30 Radiological Scoring Methods in AS. Reliability S. Kapur, J.A. Brunet, R.J. McKendry.190
Enhanced CorKentrations of IL-16 Are Associated and Change over 1 and 2 Years
with Joint Destruction in Patients with RA A. Spoorenberg, K. de Vlam, Correspondence
L R. Lard, B.O. Roep, R.E.M. Toes, T.W.J. Huizinga. . 35
S. vanderLinden, etal.125 Economic Cost and Epidemiological
VDinaA RluSAe2 8o-f3 DCiosmeapsaer Aedc ttiovi AtyC SRc-oDreef 2in8e d(D RAeSm28is)s aionnd BOerihgpine tL’si vDinigse ians Ge einr mPaantiye:n Ats Coof mGpearmraatinv ea nAdn Taluyrskiiss h CRehpalrya cRt.e rRisotbicinss oonf .FM G.E. Ehrlich.119955
A. Balsa, L. Carmona, I. Gonzalez-Alvaro, etal.40 I. Kotter, R Vonthein, C.A. Muller, I. Gunaydin, Reply PL. Dobkin, S. Bernatsky.195
Participation in Paid and Unpaid Work by M. Zierhut, N. Stubiger .133 Letter
Adults with RA C.L. Backman, S.M. Kennedy, The Efficacy and Cost Effectiveness of N of 1
A. Chalmers, J. Singer.47 Studies with Diclofenac Compared to Standard An Unusually Complicated Case of Primary SS:
Comorbidity in Patients with RA: Effect on Health- Treatment with NSAID in OA Developnoent of Transient “Lupus-type"
RCel.Eat. eJda cQoubai,l iHty. Jo. fD Linifaen tI,. RGu.Ap.pM. .H v.Can. Bdeonsh Buiozse.n, 58 EJf.f iEc.a cPyo paen.d M S. aPferatysh okfe rT, rJa.m Aanddoelr/s Aonc.etaminophen 140 ARReu.jtAeoc.a tAniotsinhb eordsoiens, FY.o Sllhooweinnfge lSd,i lCic oBnoe sInmiapnl.ant 196
Ability of Foot Radiographs to Predict RA in Tablets (Ultracer) as Add-on Therapy for OA
Patients with Early Arthritis V. Devauchelle Pensec, Pain in Subjects Receiving a COX-2 NSAID: A Book Review
NAu. trSiaernatu Ixn,t aJk.Me .a ^nrdt hDeileott Q. eutaalilt.y in Patients 66 MPluaclteicbeon-tCero, nRtraonldleodm Tirzieadl , Double-Blind, Rheumatoid Arthritis.198
with SLE on a Culturally Sensitive Cholesterol R. Emkey N. Rosenthal, S-C. Wu. D. Jordan. Correction
Lowering Dietary Program M Kamin .150
M. Shah, B. Adams-Huet, A. Kavanaugh, OMERACT Rheumatoid Arthritis Magnetic
Y. Coyle, P. Lipsky.71 Risk Factors for Knee OA in Japanese Women: Resonance Imaging Studies. Core Set of MRI
N-Acetyl Transferase Genotypes in Relation to Heavy Weight, Previous Joint Injuries, and Acquisitions, Joint Pathology Definitions, and the
Risk of Developing SLE Occupational Activities OMERACT RA-MRI Scoring System
G.S. Cooper, E.L Treadwell, M.A. Dooley. N. Yoshimura, S. Nishioka, H. Kinoshila, etal.157 M. Ostergaard, C. Peterfy, P. Conaghan, etal..198
E.W. St.Clair, G.S. Gilkeson, J.A. Taylor .76 Etidronate Prevents High Dose Glucocorticoid
IL-1a Single-Nucleotide Polymorphism Induced Bone Loss in Premenopausal Individuals Notices.xi
Associated with SSc B. Huiyrova, J. Lukac, with Systemic Autoimmune Diseases
V. Bosak, M Buc, R.M. du Bois, M. Petrek.81 S. Nakayamada, Y. Okada, K. Saito, Y. Tanaka .... 163 Online Instructions.viii
VOLUME 31: NO. 2 FEBRUARY 2004
Editorials A Web-Compatible Instrument for Measuring Self- Autoimmune Response to Proteasome Activator
Reported Disease Activity in Arthritis 28a in Patients with Connective Tissue Diseases
Translating Research into Practice: Acetaminophen N. Athale, A. Sturley, S. Skoczen, A. Kavanaugh, M. Matsushita, Y. Takasaki, K. Takeuchi, H. Yamada,
in Osteoarthritis Revisited L Lened . 223 R. Matsudaira, H. Hashimoto.252
D.L. Scott. G. Kingsley.199
Patient Questionnaires and Formal Education Effects of Disease Activity, Pain, and Distress on
Rheumatological Creativity and Leflunomide Level as Prospective Predictors of Mortality Activity Limitations in Patients with SLE
J.M Kremer.203 Over 10 Years in 97% of 1416 Patients with RA C M. Greco, TE Rudy, S. Manzi .260
TUrtiilailtsy ABreey Sohnodr Ct, lDiniisceala sTer iLalosn g: Measuring Drug frJo. mK e1y5s oUr,S TP. rSiovkaktea ,P Er.a cKtriicsehsn anT, LPiFn cCuas,l lahan . . 229 MAa. cFrooopthea, gEe MM. iBgrriagtaionnti , InY.h Kibiipteonry, LF. aScatnotro isn, SLE
M E. Luggen .205 RA Treatment with Weekly Leflunomide: M. Leech, E.F Morand.268
An Open-Label Study J. Jaimes-Hemandez,
Articles MM ER. oDbalvesa-loSsa-nZ uRgoamslai,n ,S .R A. Srruoayroe-zB-Oortreergoo, .235 Canldo sSeL AEs sDoicaigantioosnis o: fC Haseerp-Ceso nZtoroslt eSr tRudeya cotifv Pataitoienn ts
TRACh ePe.pSo lE.pa fcuCfeleramoctwtie oosnnoft n OTB, rhaWaesle.r MaCdp. o SyOn ttou'Frndaa ycltle hopneM,t iR.SvFi.e.sE skD. aooGnrfaad Rnb ,rEA ies: lt rog.e..n 207 EMJPfMf AeCPc htaK wonlifidm eR ciTukeIkoMp,. eSPa. tienSd iPe rIaantkfiloeiwnxitsmsk iaw, biI t.T hD hRoeAmra ypsyla owns kSae, rum2 38 wDJMii.tsEh.oD . Sr. PdLLoeEarps seok .i rnA N.. oKnriiznofvlaam, Jm.Mat. oOryu iMmeut,s cJu.Llo. sGkoeoledtwailn 2, 74
Tof6h .eO TInnesfnelgut seatnrnacdne d Oo, fuM tS.c eoAxmh ioemn Ae nRf,tA eIr.: HA2 aYPlsretoraosrmsp e, ctive Study TEPrlfaeficacetambcoye naCtn oodnf tSRroaAlfl:ee tAdy RDofao nTsdeao-cFmroinilzidmeindug, s D S(FotuKudb5yl0e 6 B) ilnin d, TSOALrunaEttnci bosoovrm deLeiresu asep n uMds -yRleikelieltei sDv aainssec taehs eoe f:F AGirnostto idpM hFaonusinpfchetsoitolaintpiaiodln of
for the BARFOT Study Group.214 H. Kondo, T. Abe. H Hashimolo, etal .243 DP. D’Cruz, S. Mellor-Pita, B. Joven, etal.280
2572 The Journal of Rheiiniatoloffy 2004; 31:12
Nailfold Capillary Microscopy Can Suggest NSAID or Acetaminophen for OA of the Hip or Correspondence
Pulmonary Disease Activity in SSc M Bredemeier, Knee? A Systematic Review of Evidence and
R.M. Xavier. K.G. Capobianco. et al.286 Guidelines No Significant Sex Differences in Temporal Arteritis
E. Liozon. A-L. Fauchais. V. Loustaud. E. Vidal . 397
IL-18 Gene Polymorphism Association with A. Wegman. D. van der Windt, M. van Tulder
Severe Renal Manifestations and Renal Sequelae W. Stalman. T. de Vries .344 Reply R Nir-Paz. T. Chajek-Shaul.398
in Henoch-Schonlein Purpura M.M. Amoli, Reply J. Narvaez.399
MW..CE.. RC. aOlvlilnieor, MC.. AG. aGrcoina-zPaolerzru-Ga,a Jy. L.lor2ca, 95 tLoo Nngoenrs Upescei foicf CNOSAXI-D2-: SAp eLcoifnicg iItnuhdiibniatlo Srst uCdoym opf a3r6e3d9 DKM. AURhDl. aDn.Ld. PKreengnneadnyc. yW .R. Gilliland.400
LSyacnkt hoafs Ae sPsoolcyimatoiornp hBisemtws eaennd E Hndenoothcehl-iSalc hNoOn lein PFa.t Wienotslf ei.n K C. oMmicmhauundit. yT P.Ar.a Bctuirckee , S.Z. Zhao ... 355 RTe.pMly. BEu.Fs.h .Chakravarty, D. Sanchez-Yamamoto, 402
PuWr.pEu.Rra. OMll.iMer . AMm.Aol.i .G Co.n Gzaalreczi-aG-Paoyr ru.a, 2M.C. MCalvino, Clinical Profile of Rheumatic Disease Patients “Soft" Neurological Signs in SLE T.J. Romano 402
Galanin in Adjuvant Arthritis in the Rat RMef-eAr.r eFdit ztcoh aa rMlesu. lAti.d Aislcmipalhinreazriy. MPa.Ain. WCeanrete.r 359 Reply S.D. Denburg.402
W. Oinyang, K. Hultenby, E. Adlan.
J. Urban Lindgren .302 Functional Imaging of Pain in Patients with
A Randomized Comparative Study of Short Term Primary FM D.S. Cook, G. Lange. D.S. Ciccone, Letters
Response to Blind Injection versus Sonographic- W-C Liu. J. Steffener B.H. Natelson .364
GPEau.ti iNdeendatr seI ndwjoie.tc hFt i.P oCania nobffeu rLlo oS, chPao l uBCledoneerrty itcoo. setet raol id.s 3in 08 Aansdp eFcattsi goufe D iinu rPnaatli eRnhtsy twhmithic FitMy in Pain, Stiffness, VQauleidsittiyo nonf aSicrele Jr.oLd. ePromoale F, uL.n cBtrioownaelr .Assessment4 02
N. Bellamy, R.B. Sothem. J. Campbell.379 Lack of Association Between ICAM-1 Gene
ADAMTS-1, a Gene Product of Articular Polymorphisms and Biopsy-Proven Erythema
CDhoownndrreogcuylatetesd i nb yV IiLvo-1 aBn Ld iWn aVcihtrsom, uIsth , B. Bau. Z. Pediatric Rheumatology NMod Lo sFuemrn aMn dMe.z A, mC.o lGi. aWrc.iEa-.RP orOrluliae.r . M. Lueiro.
FNan. ,G Ae.r wPeinc,h tT.. Aigner.315 ILAR Classification of JIA: Second Revision, M.A. Gonzalez-Gay.403
Edmonton, 2001
Effect of Radiosynovectomy with Holmium-166 R E. Petty, TR. Southwood, P Manners, et al . . 390
Ferric Hydroxide Macroaggregate on Adult Equine Correction
Cartilage O T. Makela. M.J. Lammi, Case Report
H. Uusitalo, el al .321 An Unusually Complicated Case of Primary
Bone Scintigraphy Is Not a Better Predictor of Delayed Diagnosis of Takayasu's Arteritis; Sjogren's Syndrome: Development of Transient
Progression of Knee OA Than Kellgren and Total Abdominal Aorta Occlusion Treated with "Lupus-type” Autoantibodies Following Silicone
Lawrence Grade S.A. Mazzuca. K.D. Brandt. Axillo-Bifemoral Bypass H. Kart-Koseoglu. Implant Rejection
D.S. Schauwecker eta!.329 A.E. Yucel, A. Tasdelen, F Bovyat.393 R A Asherson, Y. Shoenfeld, C. Bosman.405
A Randomized, Single-Blind Comparison of the Images in Rheumatology Notices.xiii
Efficacy and Tolerability of Hylan G-F 20 and Online Instructions .406
Triamcinolone Hexacetonide in Patients with OA of Fatal Occlusive Vessel Disease in a Patient with
the Knee D. Caborn. J. Rush. W. Lanzer Systemic JIA H Mangge, B HeinzI. H-M. Grubbauer
D. Parenti. C. Murray.333 M Aschauer, M. Tillich.396
VOLUME 31: NO. 3_ MARCH 2004
Editorials Autologous Hemopoietic Stem Cell The Cervical Spine in Calcium Pyrophosphate
Transplantation in Severe RA; A Report from the Dihydrate Deposition Disease. A Prevalent Case-
Clinical Trials, Outcome Measures, and Response EBMT and ABMTR Control Study A. Finckh. D. Van Linthoudt,
Criteria S R. Pillemer B Tilley 407 J.A. Snowden. J Passweg. J.J. Moore, etal... 482 B. Duvoisin. P Bovay, J-C. Gerster.545
Defining Therapeutic Success in Rheumatoid Patients with RA and SLE Have Increased Renal Multifaceted Educational Program Increases
Arthritis Clinical Trials: From Statistical Excretion of Mitogenic Estrogens in Relation to Prescribing of Preventive Medication for
Significance to Clinical Significance A. Maelzel 411 Endogenous Antiestrogens Corticosteroid Induced Osteoporosis M Naunton.
Suboptimal Osteoporosis Management: C. Weidler P. Hade, J. Schedel. M Schmidt. G.M. Peterson. G. Jones, G.M Griffin.
Moving Beyond Detection J. Scholmench. R.H. Straub.489 M.D. Bleasei.550
T. Neogi. J.J. Allison.413 Triple Association Between Hepatitis C Virus Lubricating Ability of Aspirated Synovial Fluid from
Hepatitis C and B Cells; Induction of Autoimmunity Infection, Systemic Autoimmune Diseases, Emergency Department Patients with Knee Joint
aSntidm Lulyamtiopnh oTphroroliufegrha tCioenll -MSauyr fRaceef lRecetc Cephtroornsi c anOd. TBr eCjoe,l lM L. yGmaprchioam-Caa rraMs.c oR.a emt oasl .Ca4sals. 95 Synovitis G.D. Jay. K.A. Elsaid, J. Zack, etal. . . . 557
G. Starkebaum. E.H. Sasso.416 Autoantibodies Against a-Fodrin in SS with Efficacy and Safety of 5% Ibuprofen Cream
Estrogen Metabolites: Increasing Evidence for Neurological Manifestations Treatment in Knee OA. Results of a Randomized.
Their Role in Rheumatoid Arthritis and Systemic J. de Seze, S. Dubucquoi. A-L. Fauchais. et al . 500 Double-Blind, Placebo-Controlled Study
Lupus Erythematosus M Cutolo 419 K. Tmavsky, M. Fischer, U. Vdgtle-Junkert.
Sensitivity and Specificity for Primary SS of F. Schreyger.565
IgA and IgG Anti-a-Fodrin Antibodies Detected
Articles by ELISA Hospital, Pharmacy, and Outpatient Costs for
PAoslsyomcioartpehdi swmit hin R PAr oinm Wotoemr Rene gion of IL10 Gene Is EAre. cRtiulfef aDttiy. sPf.u Oncsttiuonni. AP.s Gsorycpiaiotetids, weli tahl .S.cleroderm5a0;4 ODA. Wan. dM Capherlo, nMic. SBhaacinkl iPnaei, nK . Paez, M. Gunter. . . 573
L. Padyukov. A-M. Hytonen, M. Smolnikova, et al. 422 A Case-Control Study of Men with Scleroderma Lyon Schuss Radiographic View of the Knee.
TNF-a Promotes the Expression of Osteoprotegerin and RA P. Hong, J.E Pope. J M Ouimet. E. Rullan, Utility of Fluoroscopy for the Quality of
in Rheumatoid Synovial Fibroblasts A. Kubota. J.R Seibold.508 Tibial Plateau Alignment
K. Hasegawa. T. Suguro, Y. Koshihara.426 Elevated Circulating CD40L Concentrations in T. Conrozier. P Mathieu. M. Piperno. etal.584
Erythromycin Suppresses the Expression of Patients with SSc K. Komura. S. Sato. M Hasegawa. Are Preferences for Cyctooxygenase-2 Inhibitors
Cyclooxygenase-2 in Rheumatoid Synovial Cells M. Fujimoto. K. Takehara.514 Influenced by the Certainty Effect? L. Fraenkel.
T Fumimori. S. Honda. K Migita. et al 436 Geographical and Genetic Factors Do Not Account D. R Wittink. J. Concato, T. Fried.591
for Significant Differences in the Clinical Spectrum
Polymorphisms in the MBL Gene Are Not of GCA in Southern Europe M A. Gonzales-Gay. Prevalence of Rheumatic Diseases in Brazil:
Associated with Radiographic Erosions in L. Boiardi, C. Garcia-Porrua, P. Macchioni. A Study Using the COPCORD Approach
Rheumatoid or Inflammatory Polyarthritis J C. Amor-Dorado. C. Salvarani.520 E. R. Senna, ALP De Barros, E O. Silva, etal . . 594
A. Barton. H. Platt. F. Salway. et al.442
Uveitis as the Initial Clinical Manifestation in Clues to Pathogenesis of FM in Pafients with
Expression of IL-12R and IL-18R on CD4+ Patients with SpA J Fernandez-Melon. Sickle Cell Disease N. Schlesinger.598
T TC. Aeliltsa .f rMo.m Y Pamataimenutrsa .w Mit hK RaAw ashima. el al . . . . 448 S. Munoz-Fernandez, V. Hidalgo, etal. 524 Historical Vignette Professor Eric Bywaters,
Reactive Arthritis Following an Outbreak of 1910-2003. Memories of Taplow H.A. Smythe . . 601
Immune Activation and Depression in Women with Campylobacter jejuni Infection T. Hannu. M. Kauppi,
RA A.J. Zautra, D C. Yocum. I Villanueva, et al. . 457 M Tuomala, I. Laaksonen. P. Klemets. M. Kuusi . 528
Pediatric Rheumatology
Role of mRNA Expression of Transcription Factors Successful Short Term Treatment of Patients with
in Glucocorticoid Sensitivity of Peripheral Blood Severe Undifferentiated Spondyloarthritis with the MHC Class I Overexpression on Muscles in Early
Mononuclear Cells and Disease State in RA Anti-TNF-a Fusion Receptor Protein Etanercept JDM C.K.C. Li, H Varsani. J.L. Holton, B. Gao,
K. Onda, E. Rimbara, T. Hirano. et al.464 J. Brandt. A. Khanouzov, J. Listing, el al.531 P Woo. L.R. Wedderbum.605
PParotigernets Rsieotne notfio RnA a nDdu rHinagn da- W3-Yriseta rR Pardoisopgeracptihv e AD oPcourmtaebnleta Dtioignit aolf MPeicriruonpghuoatol gNraaiplfhoyl dU Cnaitp fiollra rRya pid Decreased Pain Threshold in Children with
Study That Prohibited DMARD Changes in Autoimmune Connective Tissue Growing Pains PJ Hashkes. O. Friedland.
H E. Paulus. D. Di Primeo. J. T. Sharp, el al.470 Diseases R.D. Sontheimer 539 L. Jaber. H A. Cohen, B. Wolach. Y Uziel. 610
Conleni Index to Volume 31 2573
Case Reports Arthritis Induced by Corticosteroid Crystals Therapeutic Implications for Interferon-u
E. Seivi, R. De Stefano, S. Lorenzini, in Arthritis I. Kotter, N. Stubiger.624
CPuirlcmuolantainryg HVEyGpeFr tCroopnhciecn Otrsatteiooanrst hinro ap aCthasye. of R. Marcolor)go.622 Reply E.N. Fish.624
Correlation with Disease Activity
F. Ol^n, M. Ponela, C. Navarro, el al.614 Letter
Unusual Differential Diagnosis of a Swollen Toe Correspondence False Positive Parvovirus Serology
M. Wahle, C.G.O. Baerwald.617 Macrophage Activation Syndrome and Etanercept A H. Johnson, A. Gough.625
in Children with Systemic JRA
Images in Rheumatology H. Sarwar, L.R. Espinoza, A. Gedalia.623
Notices.xvi
DISH: Isolated Involvement of Cervical Spine in a
Young Patient R. Mader.620 Reply A. V. Ramanan, R. Schneider.623
VOLUME 31: SUPPLEMENT 69 MARCH 2004
Longterm Followup of Patients with Rheumatoid Arthritis
The Worldwide Experience
Edmonton, Alberta, Canada — August 27-28, 2001
Introduction J.J. Rasker, F. Wolle.1
Session 1: Methodology of Data Collection
Outcome After 40 Years with RA: A Prospective Study of Function,
Disease Activity, and Mortality
N.J. Minaur, R.K. Jacoby, J.A. Cosh, G. Taylor, J.J. Rasker.3
Experiences from a Prospective Early RA Study in Southern Sweden
K. Eberhardt.9
The Nijmegen Inception Cohort of Early RA P.M.J. Welsing. P.L.C.M van Riel.14
Longterm Studies in RA — The German Experience
A. Zink. D. Huscher for the German Collaborative Arthntis Centres.22
Progressive and Nonprogressive RA Over a 10-Year Period in Japan
K. Watanabe. S. Urata, K. Suzuki. M. Ohba, Y. Inagaki.27
Methodological Issues in Conducting and Analyzing Longitudinal
Observational Studies in RA D.P.M. Symmons.30
The Population Based Studies in RA. A Method of Longterm Followup Studies
T.K. Kvien, T. Uhlig .35
Session 2: Radiographic Outcomes
A Short History of Data Banking in the United States from 1974 to 2003
F. Wolfe.41
Assessment of Radiographs in Longitudinal Observational Studies
D.M.F.M. van der Heijde.46
Is It Possible to Predict Radiological Damage in Early RA? A Report on the Occurrence, Progression, and Prognostic Factors of
Radiological Erosions over the First 3 Years in 866 Patients from the Early RA Study (ERAS)
J. Dixey, C. Solymossy, A. Young, on behalf of the Early RA Study .48
Radiological Progression in Established RA D.L. Scott.55
Ten-Year Radiographic Outcome in Patients with RF Positive RA Treated with Aggressive Immunosuppressive Combination
Therapy
J. Darmawan, J.J. Rasker, H. Nuralim.66
3
VOLUME 31: NO. 4 APRIL 2004
Editorials A Comparison of MRI, Sonography, and |
Articles Radiography of the Hand in Patients with Early RA j
Fibromyalgia Among Friends H.A. Smythe.627 J.L. Moving. R. Buchbinder, S. Hall, el al.663
FiWbr.Ro.m Nyiaellgsoian:, BMe. yHoanrdth t.he Rhetoric 631 OwBriiotahla vaRanAidl a MbS.i uiHibtyoc euoktfas tHnraei,go hCue.s r H ADadoamsgesi mnMiasT,t rXaC t.Ci oNonme eipnf,a Priantgie nts IUdseinntgif iac aPtoiornta bolfe W MrRisIt Saynsdt eMmC CP oJomipnat rEedro tsoio ns
To Fibromyalgia Nihilists; Stop Pontificating J. Proost, A. Knuif, M. van de Laar.645 Conventional Radiographs J.V. Crues, FG. Shellock,
and Test Your Hypothesis D.J. Wallace .632 S. Dardashti, T.W. James, O.M. Troum.676
Concomitant Medication Use in a Large,
FQiuberosmtioyna?lg Dia.:L .T Go oDldiaegnnboersge. or Not. Is That Still t6he3 3 TInritaelr noaf tAionnaakl,i nMrau, lati cRenetceorm, Pbliancaenbt oIL C-1o nRtreoclelpedto r SPtriemmuelnatoepda Pusroald uScetxiounal aDndim Soercprheitsimon i no fL TPNSF-
Fibromyalgia: The Answer Is Slowin' in the Wind Antagonist, in Patients with RA G. Moxley. A.G. Stern, P. Carlson. E. Estrada.
K.P. White.636 J. Tesser, R. Fleischmann, R. Core, eta!.649 J. Han, L.L. Benson.686
Oxygen Uptake During Walking in Patients Severe RA, Worse Outcomes, Comorbid Illness,
Is There a Role for Extremity MRi in Routine with RA — A Controll^ Study and Sociodemographic Disadvantage Characterize
Clinical Management of Rheumatoid Arthritis? M.R.P. De Carvalho, A.S. Tebexreni, RA Patients with FM
C.G. Peteriy.640 C.A.F. Salles, T.L.B. Neto, J. Natour.665 F Wolle, K. Michaud.695
2574 The Journal of Rheumatology 2004; 31:12
Clinical Predictors of Recovery and Complications No Effect of Antiviral (Valacyclovir) Treatment in Correspondence
in the Management of Recent-Onset Renal Failure FM: A Double Blind, Randomized Study
in Lupus Nephritis: A Chinese Experience S.A. Kendall, M.L.C. Schaadt. L.B. Graft, el al. . 783 still a Blind Spot for Osteoporosis Prevention
L. Liang, X. Yang. H. Xu, eta!.701 and Treatment of RA
SLE as a Cause and Prognostic Factor of Acute HPayinp oitnh eFsMis RD. iGeteaeryn eGn,l uEta Lm. aJaten sWseilnl sN. ot Affect B.M. Jolles, E.R. Bogoch.822
Pancreatitis V. Pascuat-Ramos, A. Duarte-Rojo, J.W.G. Jacobs. W.A. van Staveren.785 Reply J. Zochling. L. March.822
A.R. Villa, eta!.707 Costs of Treating Bleeding and Perforated Peptic Fatigue and Psychological States and
CVD a Hazard Despite Improved Prognosis in Ulcers in The Netherlands H.T.J.I. De LeesI, Traits in SLE: Association or Causation?
Patients with SLE: Results from a Swedish H E M. van DIeten. M.W van Tulder, W.F Lems, N.H. Hjollund. O.N. Hansen.823
Population Based Study 1964-95 B.A.C. Dijkmans, M. Boers.788 Reply R. Omdal.823
L. BjornSdal, L. Yin, F. Granath, L. Klareskog,
A. Ekbom.713 Eleventh International Vasculitis and ANCA Hands-on Treatment in Rheumatology
Workshop, October 2-5, 2003, Prague, Czech E. Ernst.824
wPoitlhy mSSo rapnhdis SmLsE o f IL-11) Gene in Japanese Patients Republic S. Carelte. 792 Reply M-A. Filzcharles.824
Y. Muraki, A. Tsutsumi, R. TakahashI, eta!.720 Another Look at WG-Associated Pachymeningitis
CD4+ T-Lymphocytopenia — A Frequent Finding in PM. Aries. E. Reinhold-Keller, W.L. Gross.825
Anti-SSA Antibody Seropositive Patients with Pediatric Rheumatology Reply A.G. Fam.825
PRri.m Marayn tShSor pTe. ,M Ga.n Hdle, nAr.i kBsrseodnb.erg7, L.T.H.2 Jacob6sson, SLeurnugm D Liseevaesl eo fin K PLa-6ti eanst sa wMitahr kJeurv oefn Iinlete SrsStict ial TAr iRala nodf oam Tiozpeidc,a lD Courebalem B Clionndt,a Pinlaincge bGol uCcoonstarmolliende
SS with Myalgia Is Associated with Subnormal R. Vesely, V. Vargova, A. Ravelli. et al.795 Sulfate, Chondroitin Sulfate, and Camphor
Secretion of Cytokines by Peripheral Blood for OA of the Knee J Theodosakis 826
MCo. nEokneurfcellet,a rJ .C Eerlnlse rPu.d Eh,r ikT.s sSokno, gCh.. Andersson. 729 IMmomleucnuoleh iEsxtopcrheesmsioicna lo An nMaluysscilse oBf iAopdshye sSiopne cimens Letter M L. Grove.826
from Patients with Juvenile Dermatomyositis Reply M. Cohen.826
Cytochrome P450 1A1 and MnSOD Gene A. M.E. Sallum, S.K.N. Marie. A. Wakamalsu, et al 801
Polymorphisms in Behpet's Disease J-H. Yen.
W-C. Tsai. C-H. Lin. T-T. Ou. C-J. Hu, H-W. Liu. . 736 Infliximab as a Novel Therapy for Refractory Letters
Kawasaki Disease
HIV-Associated Rheumatic Disorders in the HAART J.E. Weiss. B.A Eberhard. D. Chowdhury, Fibromyalgia — Real or Imagined? A. Morris . . 827
EAra. BJe.r mMaanr.q uLe.Rz.. CE.sSp.i nRoezsat.repo, L. Candia, 741 B. S Gottlieb.808 Fibromyalgia. Reflections About Empirical
Science and Faith L.C. da Silva. 828
Kyphosis Does Not Equal Vertebral Fractures: the
Rancho Bernardo Study D.L. Schneider, Systolic Blood Pressure in Patients with OA
D. G. von Muhlen, E. Barretl-Connor, D.J. Sartoris 747 Case Reports and RA J.D Spence 829
Radiographic Features of Lumbar Disc Pleural Effusion as a Manifestation of Lyme Acute Polyarthritis Related to Once-Weekly
DPyeeg. eDn eMra. tRioenid a, nd Self-Reported Back Pain S.R. DHjs-0C3.S CGh en. C-M. Shih. J-H. Lai. L-L. Chao. AJl.eCn. dGroenrsatteer ,i nF . aN Wicoolme.an with Osteoporosis 829
R. Smith, el al.753 S-Y Kuo. D-M. Chang.811 Wegener's Granulomatosis with Massive Skin
SANodactuiiolatnls aawln iCdth o PmHeimrps uoannniadtly KCBnoaensees deAq rSuthuerrnovcpeelyas s Io.t yfB . DoAui slFraorbnei,nl ictyh in DSMyen.s tdLrruiodcamtri,ve A e. AZrlothtorigtoisr sikni , aP P Latainegnetv witzit.h Haim-Munk NAAe.. c FCrolyasbkiu,s l Js.k aM. uAs.i aLl.i nAd. aSs.y dWo.rJ.. Sydor. 830
S. Poiraudeau, P. Ravaud. et al. 759 N. Tweezer-Zaks. G. Zandman-Goddard.814 Juvenile Polyarteritis: Is It a Different Disease?
Effect of a Cetylated Fatty Acid Topical Cream on Docetaxel (Taxotere) Induced Subacute Cutaneous S. Ozen.831
FwJui.tMnhc .Ot iAoAnn daWel r.JMs.o oKnb,r iaeleittm ya ela.rn, dN .QA7u. aRliatlya mofe6 sLsi.f e of P7atients LMup. Cus hEenry. tAh.eNm. aCtrooswusso:n R, Mep. oWrtc oxjff t4er ,C Mas Be.s Luca. Book Review
C M. Magro.818 Targeted Therapies in Rheumatology.832
A Double Blind, Randomized, Multicenter, Parallel
Group Study of the Effectiveness and Tolerance of Images in Rheumatology Notices .xiii
Intraarticular Hyaluronan in OA of the Knee Spontaneous Regression of Disc Herniation Online Instructions 834
R. Day. P. Brooks. PG. Conaghan. M. Petersen. . 775 A. Grasland. J. Pouchot. P. Vinceneux.821
VOLUME 31: SUPPLEMENT 70_ APRIL 2004
Proceedings of an International Workshop on
Osteoarthritis Outcomes
Indianapolis, Indiana, USA
December 13-14, 2002
Introduction: Proceedings of an International Workshop on Osteoarthritis Outcomes K.D. Brandi .
Obesity and Vocational and Avocational Overload of the Joint as Risk Factors for Osteoarthritis D. T. Felson . .2
Do Risk Factors for Incident Hip Osteoarthritis (OA) Differ from Those for Progression of Hip OA? M.C. Hochberg . .6
Who Gets Osteoarthritis and Why? E.L. Radin. .10
Specific Gene Defects Leading to Osteoarthritis R. W. Moskowitz. .16
How Important Are Genetic Factors in Osteoarthritis? M. Doherty. .22
Markers of Altered Metabolism in Osteoarthritis L.S. Lohmander. .28
Radiographic Issues in Imaging the Progression of Hip and Knee Osteoarthritis E. Vignon . 36
Cartilage Oligomeric Matrix Protein as a Marker of Osteoarthritis J.M. Jordan . 45
Relationship Between Symptoms and Structural Change in Osteoarthritis.
What Are the Important Targets for Osteoarthritis Therapy? PA. Dieppe. .50
Recent Approaches to Understanding Osteoarthritis Pain L A. Bradley. .54
Pushing the Limits of Patient-Oriented Outcome Measurements in the
Search for Disease Modifying Treatments for Osteoarthritis M.H. Liang . .61
Outcome Measures for Clinical Trials of Disease Modifying
Osteoarthritis Drugs in Patients with Hip Osteoarthritis M. Dougados. .66
Inflammation in Osteoarthritis S.B. Abramson . .70
The Importance of Subchondral Bone in the Progression of Osteoarthritis D.B. Burr. .77
Impact of Exercise on Osteoarthritis Outcomes M.A. Minor . 81
The Role of Proprioceptive Deficits, Ligamentous Laxity, and Malalignment
in Development and Progression of Knee Osteoarthritis L. Sharma. .87
Content Index to Volume 31 2575
VOLUME 31: NO. 5 MAY 2004
Editorials Development of the BD-QoL: A Quality of Images in Rheumatology
Life Measure Specific to Beh9et's Disease
Whither the ACR20? G. Gilworth, M A. Chamberlain, B. Bhakta. Three-Dimensional Power Doppler Sonc^raphic
IsD E TS RF ethlseo nP.referable Measure of the Acute 835 RDe.s oHuarsckea rUd,t iAli.z aStiilomna nin, AP.o Tstemnneannot.pausal 931 VJi.s uSatrluiznakt,i oUn. oLfa Sngyen ov.ial1 Angio0genesi0s in RA4
PHh.aEs.e P Rauelsupso, rEts. eB irna hRnA.? 838 OSs.tCe.o Kpoowroaslsiks i,W Vi.tLh oSujte nInzfceildde, nMt F Br.a Fcteurrraezs. 938 Correspondence
SuY.b Aclhinmiacda,l IA.Nt.h Berrousccel.erosis in SLE 841 IPmigms uannodg Meniiccei ty of Hylan G-F 20 in Guinea TIsh De eFaadt eA o. fO Alivbds,t rI.a cCtisf:u eWntieths.o Ju.t RPoucbali.cation, Sc1ie0n0c7e
The OsteoprotegerinyOsteoprotegerin Ligand M Sasaki. T. Miyazaki, T. Nakamura. T. Takahashi, Reply P.J. Hashkes, Y. Uziel .1007
FaRm.Si.lMy:. RYoeluen gin. Inflammation and Bone Loss 844 S. Miyauchi, H. Iwata.943 Serious Gl Events from Low Dose Analgesic Use
A Population Based Historical Cohort Study RE. Tarone, L. Lipworth. J.K. McLaughlin. . . 1008
IKs nTohwe rAeb Aonuyt tChOinXg- 2E lSseel eWctei vCeo Iunldh ibPiotossr iDblryu gNse?e d to oAfr tthhreo Mteco,r tDaliictylo Afesnsaocc, iaantedd Nwaipthr oNxaenb umetone, Letter D A. Peura.1009
P. Davis. A. Juby, S. Robertson. N. Richard.847 N.L Ashworth. PM. Peloso, N. Muhajarine. Reply J.F. Fries, B. Bruce.1010
M. Stang .951 Ophthalmologic Monitoring for Antimalarial
Articles Intraarticular Osteoid Osteoma: Clinical Features, Toxicity P.P Slikakis. M. Mavrikakis.1011
Functional Status and Radiographic Joint Imaging Results, and Comparison with Reply S, Bernatsky, C. Pineau, M. Gans, A. Clarke. 1012
Damage Are Associated with Health Economic Extraarticular Localization Diagnostic Value of Anticyclic Citrullinated Peptide
Outcomes in Patients with RA M. Szendroi. K. Kollo, I. Antal. J. Lakatos, Antibody in RA TL TA. Jansen, G.A W. Bruyn . 1012
A. Kavanaugh, C. Han, M. Bala .849 G. Szoke.957 Reply X Zeng.1013
Criteria for Improvement in RA: Alternatives to the Rheumatic Disease in an Australian Aboriginal
ACC.RM2. 0B Dre nAs. inAglbeer.r tJ. .AG.. HBeuralinng, . HG.J. . DWubilrloiawm, s.856 CA oWmHmOu-nILitAyR i nC NOoPrCthO QRDue Seunrsvlaenyd , Australia. iPtRsr e. CvSlaailnnemincaacrlet iS,o ifEg .Sn Giilfedicnmate nAzc-meC ayslaonidoovasiss, Min. RSoAl ea, nedta ! 1013
Glucocorticoids and Insulin Sensitivity in RA N. Minaur, S. Sawyers. J. Parker. J. Darmawan 965
PMH. V Delelesrs.ein, B l Joffe, A.E. Stanwix. B.F Christia8n,6 7 SFoigllnoiwficinagn tT Votaarli aJtoioinn tE Axritshtsro ipnl aHsotym e Care Services RPe.p Hly iRss. aMriais,r aA. . AA. gWgaarkwhaiul., N Krishnani. 1014
Increase of COX-2 Expression by IL-15 in N.N Mahomed. J.T.C Lau, M.K S Lin. R Zdero. Macrophage Activation Syndrome Due to MTX
Rheumatoid Synoviocytes J.R. Davey.973 in a 12-year-old Boy with Dermatomyositis
S-Y Min. S-Y. Hwang. Y-O. Jung, eta!.875 Depressed Mood Impedes Pain Treatment G. Sterba, C. Rodnguez, S. Sifontes. P. Vigilanza .1014
Relative Sensitivity to Change of the ESR and Response in Patients with FM Reply A. Ravelli. A. Martini .1015
Serum CRP Concentration in RA M.M. Ward . . . 884 A Finset. S.H. Wigers, K.G. Gbtestam.976 Breast Implant Related Disease
Radiation Synovectomy of the Ankle with 75 MBq S. Rothschild, M. Helbling II.1015
Colloidal "*Rhenium-Sulfide: Effect, Leakage, and Pediatric Rheumatology Reply R.C.W. Vermeulen, HR. Scholte.1015
Radiation Considerations FM. van derZant.
Z.N.Z. Jahangier, J.D. Moolenburgh, W. van der Zee. Assessment of Osteoporosis by Quantitative Letters
R.O. Boer, J.W.G. Jacobs.896 Ultrasound versus DEXA in Children with Chronic
Economic Evaluation of Folate Supplementation Rheumatic Diseases C. Hartman. R. Shamir, Hepatitis C Virus and RA: Further Pieces to the
During MTX Treatment in RA O. Eshach-Adiv, G. losilevsky. R. Brik.981 Puzzle A. Csepregi, G. Po6r, E. Nemesanszky . . 1016
M. Hartman. A.E. van Ede. J.L. Severens. OPG/RANK-L System in JIA: Is There a Potential Etanercept in Breast Milk
R.F.J.M. Laan, L.B.A. van de Putte. Modulating Role for OPG/RANK-L in Bone Injury? M. Ostensen, G O. Eigenmann.1017
G.J. van der Wilt .902 L. Mas/, G Simonini, E. Piscitelli, et al.986 Severe Recurrent Neurological Disease in the
Duplex Study of the Carotid and Femoral Arteries of NO-Derived Species in SF from Patients with JIA MAGIC Syndrome E. Gertner.1018
Patients with SLE: A Controlled Study A.P.N Lotito, M.N. Muscara, M.H.B Kiss, eta! . . 992
T. Wolak, E. Todosoui, G. Szendro, eta!.909
TNhe. O E.f fGehcta uosfs yR.a cWe. Lo. nS iDbbisitet aJsr,e A A.Dct. ivBiatyn kihnu SrsLtE. ASynnodthroerm Pea atinedn tJ RwAith P C. Rhroosmeno. sRo.mJ eH 1o8p kDine. letion CRhoeurmreatcoitdi oArnth ritis Treatment with Weekly
C.R. Qualls .915 D.N. Glass. T.B. Graham.998 Leflunomide: An Open-Label Study
ASancticbhoadrioems tyoc eTsi scseuree vTirsaianes ginlu AtaSm ainndas Pe saAn d Case Report JR. . JSaulmareesz--HOetrenroa,n dMe zE,. MD.a Rvaolbolse-Zs-uSgaans tRi. oman.
L. Riente. D. Chimenti, F. Pratesi, el al.920 Embolic Complications of a Mitral Valve S Arroyo-Borrego.1019
Unique Angiopathy After Herpes Virus Infection Rheumatoid Nodule Notices. xxi
J. Shimizu. A. Inalsu. S. Oshima. T Kubota.925 H. Kang. M. Baron.1001 Online Instructions .1020
VOLUME 31: NO. 6 JUNE 2004
Editorials Radiographic Hand Joint Space Width Assessed Effects of Anakinra Monotherapy on Joint
by Computer Is a Sensitive Measure ot Change in Damage in Patients with RA. Extension of a
Is There a Rationale for Switching from One Early RA J. Angwin, A. Lloyd. G. Heald. G. Nepom, 24-Week Randomized, Placebo-Controlled Trial
Anti-TNF Agent to Another? B. Haraoul.1021 M. Binks. M.F James.1050 B. Bresnihan, R Newmark, S. Robbins,
RMhileduemr oarto Iisd T Arertahtrmiteisn:t IIsm thpero Dviinsge?a se Becoming VAabrniaobrimlitayl iotife sP rine cRisAio bny inE xSpceorriienngc eRda dRieoagdraeprsh ic HC lKin.i cGale nInavnet,s tfiogra ttohres .European Group of 1103
S. Walji. V.P Bykerk.1023 J.T. Sharp. F. Wolte, M. Lassere, el al .1062 Comparative Study of Serum Surfactant Protein-D
MWSeh. aaBst urIersai naleg yM .Piantimieanlt CHleinailctha llSyt aItmups oirnt aRnAt —Di fferen1c0e2? 6 RPOaavtdeirieo n5gt rsYa wepahirtihsc ETP. arSroloygk rkReaAs,s .i HoR. neK sIausu lGttisae iotntfei nn3g, C Mohilodertrs i n aMFnSiabd. rr SkoKeasLrtisos-6 .f oCKro. MnYcoaennnaittboraar.it niMog.n tsHh eian sA ePgcaatitwvieiatn.y t Kso .f w TPitauhkl emShSoarcna a.1a rsy1 12
What I Would Like to Know About Leflunomide A. Hakkinen, P. Hannonen.1073
J.M. Kremer. 1029 Effects of High Dose Methylprednisolone Pulse Cine SnStr oamnde rIes PUrnoitfeoirnm Cly IAs as sToacrigaetet do fw Aithu toantibodies
Coping with Chronic Pain: What Can We Learn from Therapy on Bone Mass and Biochemical Markers of Antibodies to Ro and La S.R. Pillemer.
Pain ^If-Efficacy Beliefs? D. Saunders.1032 Bone Metabolism in Patients with Active RA: L. Casciola-Rosen, B.J. Baum, A. Rosen.
Hypertension, NSAID, and Lessons Learned AS tu12d-yM Bo. nFthre Rdiaannid. oPm iFzaeldse tPtir,o Ss.p Becistoivgen oC. oent tarlo ll.e d1 083 A C. Gelber .1121
J.E. Pope.1035 The Clinical Assessment of Patients with PsA:
Progression of RA on Plain Radiographs Judged Results of a Reliability Study of the
Articles DRihfefeurmenattlyo lboyg iEstxsp ert Radiologists and SDpo.Dn.d Gylloadamrthanri. tiRs JR. eCsoeoakr.c hC .C Socnhseonrttaigu,m e toaf lC .a1n1ad2a6
AMcatcivroatpiohnag oef MSyignroavtiioanl CInehlli bpi3to8r yM AFaPc Ktoirn ase by KF.. BGurbulyern,e Rst.e yWn,e iSje.r sv, aDn. dvearn L dinedre Hn,e iRjd. eL.a1nde0we8, 8 AAnAti--AILm-6y lRoiedcoespisto Mr .A Mntiihbaorad,y M I.n Shihbiiintsa ,M Nu. rNiniesh imoto,
L.L. Santos. D. Lacey. Y. Yang. M. Leech, High Sensitivity C-Reactive Protein as a Disease K. Yoshizaki. T. Kishimoto. K-l. Akamatsu.1132
E.F. Morand.1038 Activity Marker in RA
Expression of Tristetraprolin (G0S24) mRNA, a PH. Dessein. B.l. Joffe. A.E. Stanw/x. 1095 IGneflnuee nPcoel yomf oSrepruhmism Asm oynl oRide nAa l( SAAmAy1l)o aidnods iSsA, A2
Regulator of TNF-a Production, in Synovial Tissues The Efficacy of Switching from Etanercept to and on SA/UCRP Values in Patients with Familial
of Patients with RA A. Tsutsumi, E. Suzuki. Infliximab in Patients with RA K.E. Hansen. Mediterranean Fever in the Turkish Population
Y Adachi. et al.1044 J.P Hildebrand. MC. Genovese, etal.1098 A Bakkaloglu. A. Duzova. S Ozen. etal.1139
2576 The Journal of Rlieuniafolo^y 2004; 31:12
Blood Pressure Destabilization and Edema Among The Comprehensive OA Test: a Simple Index for Case Reports
8538 Users of Celecoxib, Rofecoxib, and Measurement of Treatment Effects in Clinical Trials
Nonselective NSAID and Nonusers of NSAID L.O. Brooks, Ml. Rolfe, PA. Cheras, S.P VfyersllBO Vasopressin Cell Antibodies and Central Diabetes
RFe. cWeiovlifneg, SO. rZdhinaaor, yM C. lRineiycnaol lCdsa,r eD . Pettitt.1143 wImitpho Crtharnot nDice tMerumsicnualonstsk eolfe Staell fP-Eaifnfi cAa cRy aihnm Paant,i ents InHs.i pKiadjuiysa mina a, CP.a tTieernati, wAi. thD eS LBEei laisn, de tDaMl. 1218
Hypertension Was the Major Risk Factor Leading to G. Ambler, M R. Underwood, M.E. Shipley . . . . 1187 Identity Loss Due to Chronic Fingertip Ischemia
Development of Cardiovascular Diseases Cyclic Alternating Pattern: A New Marker of Sleep J.C. Crispin. M. Fallena, A. Kraus.1222
Among Men with Hyperuricemia Alteration in Patients with FM?
K-C. Lin, H-M. Tsao, C-H. Chen, P. Chou.1152 M Rizzi, P. Sarzi-Puttini, F. Atzeni, etal.1193 Images in Rheumatology
Different Progressions of Hyperglycemia and Physician Resources and Postgraduate Training in Diagnosis and Followup of Takayasu's Arteritis by
Diabetes Among Hyperuricemic Men and Women in Canadian Academic Rheumatology Centers: Scintigraphy with Radiolabelled tL-2
the Kinmen Study A 5-Year Prospective Study J.G. Hanly for the P. Lucia, M.G. Parisella, C. Danese, etal.1225
K-C. Lin, S-T. Tsai, H-Y. Lin, P. Chou.1159 Canadian Council of Academic Rheumatologists 1200
The Effect of a Preoperative Exercise and Letter
Education Program on Functional Recovery, Health
Related Quality of Life, and Health Service Pediatric Rheumatology Dose-Dependent Severe Arthralgia Induced by
Utilization Foliowing Primary Total Knee Gabapentin A. Almahrezi, M-A. Fitzcharles.1228
Arthroplasty Association of Single Nucleotide Polymorphisms
LD..AW. .BCe. aJuophrnes, toDn. .Lier, D.M. Davies, 1166 wPoitphuinla Ctioynto kine Genes with JIA in the Czech Notices.xi
O. Cinek, P. Vavnncova, I. Striz, etal.1206
Cartilage Destruction in Collagen Induced Arthritis
Assessed with a New Biochemical Marker for Antiagalactosyl IgG Antibodies in JIA, Juvenile
Collagen Type II C-Telopeptide Fragments Onset SS, and Healthy Children
T. Ishikawa. F. Nishigaki, S. Christgau, etal. . . 1174 N. Maeno, S. Takei, S. Fujikawa, etal.1211
VOLUME 31: SUPPLEMENT 71 JUNE 2004
Practical Management of
Rheumatoid Arthritis Patients
Treated with Leflunomide
Paris, France
16-17 May 2003
Introduction Practical Management of Rheumatoid Arthritis Patients Treated with Leflunomide
J.S. Smolen.1
The Efficacy of Leflunomide Monotherapy in Rheumatoid Arthritis:
Towards the Goals of Disease Modifying Antirheumatic Drug Therapy
J.S. Smolen, P. Emery, J.R. Kalden, etal.13
Leflunomide: A Manageable Safety Profile
P.L.C.M. van Riel, J.S Smolen, P. Emery, el al.21
Leflunomide in Combination Therapy
J.R. Kalden. J.S. Smolen, Paul Emery, etal.25
VOLUME 31: NO. 7 JULY 2004
Editorials Quantitation of Metalloproteinase Gene Expression O. Di Munno, M. Mazzantini, L. Sinigaglia, etal. 1305
MCe.Tc.h aRniticshmlins. of Erosion in Rheumatoid Arthrit1is2 29 TJinui snRschuteieou Dnm iDsatt.a olKi daa nnaedn, dPL r.PEosx. oiJmreinaatsli ectno A, tShrt.eh GrCitraiesrh tSailnya,ng oev-Piaal nnus TADh Se.Py .RsMtoe. lmeS yaomtfi cDm iRoenet vsi.nie Swu 1Dsc.Je.p Ptiabt3itliistoyn t, oR 1R.AA. :H arri0son,
Using Vaccine Responses to Plumb the A S. Whitehead. B. Bresnihan, O. FitzGerald. . 1274
IF1m2a3cm8tou rn oBlloogcikc aCdeo nwsiethq uEentacneesr coef pTtu Dm. oWr NScehceriofseilse . QoCfou Vratneicrtyiot asEtteiavrroley iA dR-nNhaealyuivsmeisa Ptooafit dIiem Snmytsnu onvoihtiiss tionl oDgMicA FReDa-t uarneds A6A3Btd4t.rm 6iBt iiPrnouanicst etiB,re aniDatti.ss o Cniinnlsi nRo1e1fA, t GDhD.ea aS ttHaianbAbgaaQhnn, k kJEss. .:F a KnA Fdr Cir si6hea4sns.,ae6n 4S, 9tK u.d My uo1rft3 a2gh0.
Blind Insight: Eyeing Anti-Tumor Necrosis Factor J.A. Singh, J.A. Pando, J. Tomaszewski,
Treatment in Uveitis Associated with Behcet's H. R. Schumacher.1281 Weather Effects in RA: From Controversy to
Disease J.T. Rosenbaum .1241 Rate of Change in Functional Limitations for Consensus. A Review W.R. Patberg, J.J. Rasker 1327
Studies of Attrition in Rheumatological Databases Patients with RA: Effects of Sex, Age, and Duration Cyclophosphamide Boluses Induce Micronuclei
V.T. Farewell.1244 ofT .IJl.l nSehsese han, S. DuBrava, J. Fifield, S. Reisine, ESLxEp rIensdsieopne nind eBnut cocfa Cl Mytoucchorsoam Cee lPls4 5o0f P2Dat6i eSnttast uwsi th
L DeChello.1286 FJ. Aceves-Avila, G.A. Esquivel Nava,
Articles M.P Gallegos Arreola, B.C. Gomez Meda,
Sources of Discrepancy in Patient and Physician G.M. Zuniga Gonzalez, C. Ramos-Remus.1335
Upregulation of Synoviocyte COX-2 Through Global Assessments of RA Disease Activity
Interactions with T Lymphocytes: G. Nicolau, M.M. Yogui, T.L. Vallochi, R.J Gianini. Osteomyelitis in Patients with SLE
Role of IL-17 and TNF-a I. M.M. Laurindo, G.S. Novaes.1293 K-C Wu. T-C. Yao, K-W. Yeh, J-L. Huang.1340
L K Stamp, L.G. Cleland, M J. James.1246 Costs of RA in France: A Multicenter Study of Features Associated with Epilepsy in the
Paracrine Upregulation of Monocyte COX-2 by 1109 Patients Managed by Hospital-Based Antiphospholipid Syndrome
Mediators Produced by T Lymphocytes: Rheumatologists F. Guillemin, S Durieux, Y. Shoenteld, S. Lev, I. Blatt, et al.1344
Role of IL-17 and IFN-y J-P. Daures, etal..1297 Incidence of Cytomegalovirus Reactivation in
L.K. Stamp, M.J. James, L.G. Cleland.1255 Effect of Low Dose MTX on Bone Density in Patients with Inflammatory CTD Who Are Under
Relationship Between Cathepsin B and Thrombin Women with RA: Results from a Multicenter Immunosuppressive Therapy
in RA T. Mishiro, S. Nakano, S Takahara, el al. 1265 Cross-Sectional Study T Mori, H. Kameda, H. Ogawa, et al.1349
Content Index to Volume 31 2577
Are There Clinical or Serological Differences Temporomandibular Involvement in JIA Letter C. Turesson, E. Matteson .1461
Between Male and Female Patients with M. Twill, S.M.L.M. Mobers. L.R. Arends, R. ten Cate, Reply S.J. Jarrett, G. Cunnane, PG. Conaghan,
PCri.m Dali^az S-LSo?p ez, C. Geli, H. Corominas, ei al... . 1352 L.W.A. van Suijiekom-Smit.1418 S.J. Bingham. M.H. Buch, M.A. Quinn.1462
Pneumococcal Vaccine Response in PsA Patients Hormone Replacement Therapy in RA
During Treatment with Etanercept Canadian Rheumatology M. Jolly.1462
PJ. Mease, C.T. Ritchlin, R.W. Martin, etal. . . . 1356 Reply H. Forsbiad d'Elia, H. Carlsten.1463
Efficacy, Safety, and Pharmacokinetics of Multiple Association Meeting
Administration of Infliximab in Behcet’s Disease Origins of Erosive Arthritis H. McGrath Jr. . . . 1463
wSit.h O Rhenfor,a Sct. oNrya kUamveuorrae. tSin. itHiso ri, eta!.1362 LFeakberu Laroyu i2s5e-, 2A8,l b2e0r0ta4, Reply B. Rothschild.1464
CRoadmiopgarraispohny oifn Pthaete Allas sCeasrstmilaegnet Vofo lLuomneg iatnuddi nal IPnotdroiudmuc Ptiorens entations 11442235 CAochmilpleasr iTsoenn dBoent wEenetnh eUsoltpraasthoyu nind aPnadti eMnRtsI wofi th
Joint Change at the Pateilofemorai Joint Posters 1427 Psoriasis
FM. Cicuttini. A.E. Wluka, J. Hankin, S. Stuckey 1369 C. De Simone, F. Di Gregorio, F. Maggi .1465
Comparison of the Analgesic Efficacy and Safety of Case Reports Reply M. Kamel, H. Eid, R. Mansour,
Nonprescription Doses of Naproxen Sodium and M. Abbady.1465
Ibuprofen in the Treatment of OA of the Knee Primary Vasculitis at High Altitude
M. Schiff. M. Minic.1373 G. Mittal, N. Hasso. P. Maddison. . Silicone Breast Implants
J.P Fryzek, J.K. McLaughlin.1466
Physical Activity and Risk of Revision Total Knee Bilateral Giant Iliopsoas Bursitis Presenting as
Arthroplasty in Individuals with Knee OA: Refractory Edema of Lower Limbs Reply F.B. Vasey.1466
A Matched Case-Control Study M. Rodriguez-Gomez. A. Willisch, L. Fernandez.
D.L. Jones, J.A. Cauley. A.M. Kriska, eta!.1384 G. Lopez-Barros, V. Abel, E. Monton.1452
Letters
Health Services Costs and Their Determinants in Collagenous Colitis with Spondyloarthropathy
Women with FM J.R. Penrod, S. Bernatsky. Presenting as FM Giant Ceii Arteritis in a Patient Taking
V. Adam, M. Baron. N. Dayan, PL. Dobkin .... 1391 S. Christopoulos, V.A. Marcus. M-A. Fitzcharles 1455 Etanercept and MTX
Prevalence of Current and Chronic Pain and Their M. Seton.
Influences Upon Work and Healthcare-Seeking: Images in Rheumatology
A Population Study Is Measurement of Serum VEGF Reliable in
B. Gerdle. J. Bjdrk, C. Henriksson, A. Bengtsson1399 Nonerosive MCP Arthritides in a Patient with DM Patients with SSc? S. Ferrero. 1468
J. Schedel, B. Butz, M. Volk, S. Feuerbach,
Pediatric Rheumatology J. Scholmerich, U. Muller-Ladner.1457 Autoantibodies to Bactericidal/Permeability-
JBIAon: eT Mreaatsms eDnet vweiltohp mGreonwt athn dH oBromnoen Me feotar b4o lYisemar sin SAp.i nNaal kTaojipmhaa, cYe. oKuasl oG, oHu. t YMamimaincakkian,g Ta. IStop, inal Tumor InPc. rGearyspiniogti sP, rFo. teCionz zain, dA .C Rauthffeapttsi.in G in SSc 1468
S. Bechtold, P. Ripperger, W. Bonfig, etal.1407 N. Kamatani.1459 Gastrointestinal Disease and PsA
Growth Hormone Is Effective in the Treatment of L. Williamson, J.L. Dockerty, N. Dalbeth,
Severe Growth Retardation in Children with Correspondence B.P Wordsworth.
Juvenile Chronic Arthritis: Doubie Blind, Placebo-
Controlled Followup Study Extraarticular RA and Drug-Induced Syndromes: Notices
M-T. Saha, J. Haapasaari, S. Hannula, Understanding the Role of TNF Inhibitors
S. Sama, H.L. Lenko.1413 G.A.W.Bruyn.1461
VOLUME 31: NO. 8 AUGUST 2004
Editorials The Clinical Effect of Dietary Supplementation with Pediatric Rheumatology
Omega-3 Fish Oils and/or Copper in SLE E.M. Duffy,
The Joy of CItrulline: New Insights into the G.K. Meenagh, S.A. McMillan, J.J. Strain, Autoantibodies in JIA: Glucose-6-Phosphate
DRhiaegunmoasitso.i dP aAtrhtohrgietins esis, and Treatment of B.M. Hannigan, A.L. Bell.1551 IsLo. mDearnanseec kIse nN Mot. aH Saupge,c ieftiac lT.arget C.P Schepp1, 630
J.A. Hill. E. Calms, D A. Bell.1471 Urine Protein-to-Creatinine Ratio Is a Reliable Oral Health of Children with JIA N. Ahmed.
Antiphospholipid Antibody Syndrome: Measure of Proteinuria in Lupus Nephritis A. Bloch-Zupan, K.J. Murray, M. Calvert.
Further Evidence to Guide Clinical Practice? L. Christopher-Stine, M. Petri, B.C. Aston D. Fine . 1557 G.J. Roberts, V.S. Lucas.1639
M.A. Crowther .1474 APS and Asymptomatic Carriers of aPL; Skin Involvement in Juvenile DM Is Associated
Observational Cohort Studies and Well Controlled Prospective Analysis of 404 Individuals with Loss of End Row Nailfold Capillary Loops
Clinical Trials — We Need Them Both! J.A. Girdn-Gonzrilez, E. Garcia del Rio, C. Rodriguez, R.L. Smith, J. Sundberg, E. Shamiyah, A. Dyer,
D.E. Furst.1476 J. Rodriguez-Martorell, A. Serrano.1560 L.M. Pachman.1644
WfrRohm.yS . I I PnNdaonu uLstsorhyn. g(earn dA cWcehpy tY Poeun Ss h(oour lOdnth’te rE "itGhiefrt)s ”1)4 78 EBAflif.n iGcda, caPyrcl aoiacf- eGMboTonX Cz aionlen Aztr,S oM:l l.Ae d VR aTazrnqiaduloe zLm-. DiGzeeold-nM,z aDelreoczau-dbLoloe, p ez, GLPoeMnngd teMerr imaent tOdun uEetntc,h onOmi.c eO Oortrfiiz gC-Ainhl ivlHadrahevzo,eo RdNE-oO. EnPfsefetettyc ,St eLotEna l 1650
J.F. Murioz-Valle, J.l. Gamez-Nava.1568
Articles Case Reports
Compliance with Allopurinol Therapy Among
Osteoprotegerin and RANK-L mRNA Expression in Managed Care Enrollees with Gout: A Retrospective Granulocyte Colony-Stimulating Factor Induces
Patients with RA and Healthy Controls Analysis of Administrative Claims A.A. Riedel, Disease Flare in Patients with ANCA-Associated
AP.. VGeaunsdeenrsb,o 1rg hRt,a uLs. ,U Pn. sSetnin, iMss. eTn.hewissen. 1483 MP. . MNaeclsDoonn. aNld. , JMos. eBphe-cRkeidr.ge, K. Wallace. 1575 VCa.s Icukliintgis- Konert, B. Ostendorf, M. Foede, etal. . 1655
Serological Bone Markers and Joint Damage Pigmented Villonodular Synovitis; A Disease in
in Early Polyarthritis L.M.A. Jansen, Increasing Prevalence of Gout and Hyperuricemia Evolution H. Bouali, E.J. Deppert, L.J. Leventhal,
I. E. van derHorst-Bruinsma, W.F. Lems, eta! . . 1491 Over 10 Years Among Older Adults in a Managed B. Reeves, T. Pope.1659
Immune Reactivity to Connective Tissue Antigens Care Population K.L. Wallace. A.A. Riedel. Septic Arthritis Caused by Actinobacillus ureae in a
in Pristane Induced Arthritis N. Joseph-Ridge. R. Wortmann.1582 Patient with RA Receiving Anti-TNF-a Therapy
R. Morgan, B. Wu. Z, Song, PH. Wooley.1497 Reproducibility of the Semiflexed P.P. Kaur, C.T. Dark, M. Chatterji, R.J. Dehoratius. 1663
Increased CD40 Expression on Articular (Metatarsophalangeal) Radiographic Knee Position
Chondrocytes from Patients with RA: and Automated Measurements of Medial Images in Rheumatology
CHo.n Gtriobtuothio, nY . toK aPwraogduucchtii,o Mn . oHf aCriygtaoi,k ienteas! .a1nd5 M0MP6 TCilbinioicfaelm Torriaall oJof iKntn eSep OacAe JW.Ci.d tBhu icnk laa nMd-uWltriicgehnt,t er CRhuetaunmeaotuosid M Naenuifterostpahtiiolinc oDfe RrmAa itnit ias :P Rataireen t with
Serum Galactosyltransferase Isoform Changes R. J. Ward. C. Peterfy, C.F Mojcik, R.L. Left . . . 1588 Palindromic Rheumatism P. Panopalis, M. Stone, A.
in RA A. Alavi, J.'S. Axford, A.J. Pool.1513 Role of EP, and EP, Prostaglandin Receptors in Brassard,
Combination Leflunomidc and MTX Therapy for Reorganization of the Cytoskeleton in Mature M-A. Fitzcharles.1666
OPBalpitneinedn-, LtPsal bawecilet hbE oAx tCcetnoivsneito rRonAl loe fFd aa Ti lRriinaagln dMoTmXi zMedo,n Dotohuebralep-y : HIu. Fmaonrt iOer,s tMe.oAc. laGsatlsla Pn.t , SAa.rJr.a zdien ,B Jr.Aum. H-Faecmkeatnt,d es 1598 Correspondence
J. Kremer, M. Genovese, G.W. Cannon, etal. .. 1521 Cost-Effectiveness of Hip Protectors in the Epidemiology of Rheumatic Diseases in Greece
Etanercept (Enbrel*) in Patients with RA with Prevention of Osteoporosis Related Hip Fractures Y. Alamanos, PV. Voulgari, A.A. Drosos.1669
Recent Onset Versus Established Disease: in Elderly Nursing Home Residents Reply A. Andrianakos. P. Trontzas, C. Voudouris. 1670
Improvement in Disability S.W. Baumgartner, S. Singh, H. Sun. A.H. Anis.1607
R.M. Fleischmann, L.W. Moreland. M.H. Schiff,
J. Markenson, J.B. Whitmore.1532 Celecoxib Effectively Treats Patients with Acute Correction
IRnRef.ls iuSxlitmtesm aob,f FD2. oSWsteou ldafeni.eds Cinl in1i6c4a2l SPtaattiuens:t s with RA 1538 SDGheo.p uWrledsaesserio rT,n eH an. ndCdinu iFi.t MiMs:/ .BCTu.r reSsanittmaisb eeMnst., aPKne.Mtdri .,C VSo.esLrt.b WuHrguh femn. a 1n6, 14 CPDaoi.p nSi n^agIuf nw-Edietfhrf siCc.ahcryo nBice lPieafisn?: What Can We Learn1 f6ro71m
Association Between SLE and H. pylori Diagnosed Separately or Concurrently
Seronegativity A.H. Sawalha, W.R. Schmid. R.L. Robinson, H.G. Birnbaum, M.A. Mortey, Online Instructions.1672
S. R. Binder, D.K. Bacino, J.B. Harley.1546 T. Sisitsky PE. Greenberg, F. Wolfe.1621 Notices.xvi
257H The Journal of Rheumatology 2004; 31:12
VOLUME 31: NO. 9 SEPTEMBER 2004
Editorials Utility of Red Amsier Grid Screening in a JIA: Parent-Child Discrepancy on Reports of
Rheumatology Clinic Pain and Disability TM. Palermo. K. Zebracki.
The No Man's Land of Undifferentiated A C. Pluenneke. PH. Blomquist.1754 S. Cox. A.J Newman. N.G. Singer.1840
infiammatory Polyarthritis S.A. Paget .1673
Angiotensin-Converting Enzyme HLA-DRB1*15021 Is the Predominant Allele in
Window of Opportunity D.E. Furst.1677 (Insertion/Deletion) and Endothelial Nitric Oxide Japanese Patients with Juvenile Dermatomyositis
Synthase Polymorphisms in Patients with SLE N. Tomono. M. Mori. S. Nakajima. et al.1847
Issues in Investigating the Genetic Epidemiology G. Douglas. C. Reilly, M.A. Dooley. G. Page.
of Disease Expression P. Rahman.1680 G. Cooper. G. Gilkeson.1756 Case Reports
The Quest for Explanations for Race/Ethnic Increased Incidence of Cervical Intraepithelial
Disparity in Rates of Use of Total Joint Arthroplasty Neoplasia in Women with SLE Treated with SLE and Calciphylaxis
G.A. Hawker.1683 Intravenous Cyclophosphamide V.M. Ognenovski. S H. Sakr. E.B. Russell. H E. Jasin.1851
W. Marder. E C Somers, C M Johnston. J.G Farrehi. Paraneoplastic Polyarthritis in an Ovarian Teratoma
Articles S. M. Selvaggi. W.J McCune.1763 W. Wiese. H. Alansari. P. Tranchida.
Immunogenetic Features in 120 Japanese Patients F Fernandez Madrid.1854
Dating the "Window of Therapeutic Opportunity" in with Idiopathic Inflammatory Myopathy Multiple Spontaneous Visceral Hematomas
Early RA; Accuracy of Patient Recall of Arthritis T. Furuya. M. Hakoda, N. Tsuchiya. et al.1768 Revealing Polyarteritis Nodosa
Symptom Onset S. Amjadi-Begvand. D. Khanna. Concordance of Disease Severity among Family Y Allanore. C Rosenberg. O. Vignaux. et al. ... 1858
G S Park. K.J Bulpitt. W.K. Wong. H.E. Paulus . 1686 Members with AS? Disseminated Prototheca wickerhamii Infection
Effect of MTX Therapy on BMD and Body S Brophy. S. Hickey. A. Menon. et al.1775 with Arthritis and Tenosynovitis
Composition in Rat Adjuvant Arthritis Measurement of Spinal Mobility in AS: J.S. Pascual. L.L. Bales. A N. Baer.1861
S. L Morgan. D-T. Chen. J. Cartee. J.E. Baggotl .. 1693 Comparison of Occiput-to-Wall and Tragus-to-Wall
Connective Tissue Metabolism in Patients with Distance L Heuft-Dorenbosch. D. Vosse. Images in Rheumatology
Unclassified Polyarthritis and Early RA. R. Landewe. et al .1779
Relationship to Disease Activity, BMD, and Vascular Endothelial Growth Factor Gene Tophaceous Pseudotumors in Polynesian
Radiographic Outcome Polymorphisms in Behpet's Disease Patients with Gout L. McLean. 1866
T Jensen. M. Klarlund, M. Hansen. K.E. Jensen. C. Salvarani. L. Boiardi. B. Casali. et al.1785 Maxillary Actinomycosis in an
H. Skjedt. L. Hyidstrup.1698 Surgical Approach for Total Hip Arthroplasty: Direct Immunocompromised Patient with Longstanding
Indirect and Total Costs of Early RA: a Randomized Lateral or Posterior? B.M. Jolles. E.R Bogoch . 1790 Vasculitis Treated with Mycophenolate Mofetil
Comparison of Combined Step-down Prednisolone, I.H. Tamer. A. Schneidewind. H.J. Linde, et al. . . 1869
MTX, and Sulfasalazine with Sulfasalazine Alone Cost-Effectiveness of Treatment Strategies
MI. .B B.Co.e rKs,o ertth aatl.s-de Bos. M.W. van Tulder. 1709 fZor-S O. AY eonf. tMhe-S K. Lnaeie, Cin- TT. aWiwaanng , et al.1797 Correspondence
Quality of Life and Economic Burden of Illness in Gastroduodenal Safety and Tolerability of Erosions Rare Without Clinically Detectable
Very Early Arthritis. A Population Based Study in Lumiracoxib Compared with Ibuprofen and Inflammation B M. Rothschild.1872
Southern Sweden M.K. Soderlin. H. Kautiainen. Celecoxib in Patients with OA Reply T. Sokka, P. Hannonen.1873
T. Skogh. M. Leirisalo-Repo.1717 C.C. Hawkey. P Svoboda.
IF Fiedorowicz-Fabrycy. eta!.1804 Pollen Allergies in Patients with SLE
Morning Stiffness in Patients with Early RA Is J. Jimenez-Alonso. J. Jimenez-Jaimez,
Associated More Strongly with Functional Disability Ethnic Differences in Health Preferences; M.V.AImazan.1873
than with Joint Swelling and ESR Analysis Using Willingness-to-Pay
Y. Yazici. T. Pincus. H. Kautiainen. T. Sokka.... 1723 M.M. Byrne. K.J. O'Malley. ME. Suarez-Almazor 1811 Reply J. Pope.1873
Risk Factors for MTX-Induced Abnormal Laboratory Assessment of Disease Severity (in Terms of
Monitoring Results in Patients with RA Function) Using the Internet S. Brophy. T. Hunniford. Letters
P.D. Kent. H.S. Luthra. C.J. MichetJr.1727 G. Taylor. A. Menon. T. Roussou. A. Calin.1819 Synovial Density of Frizzled 5-Positive Cells
Short Term Whole Body Retention in Relation Deaths from Arthritis and Other Rheumatic Does Not Differ Between Patients with RA and OA
to Rate of Bone Resorption and Cartilage Conditions, US, 1979-1998 and Is Independent of Inflammation C. Weidler.
Degradation after Intravenous Bisphosphonate J.J. Sacks. C.G. Helmick. G. Langmaid.1823 J. Schaumburger. L.E. Miller. J. Schdimerich . . 1874
(Pamidronate) in RA Septicemia with S. aureus, B-Hemolytic
S.C.L.M. Cremers, M.C. Lodder. Pediatric Rheumatology Streptococci Group B and G, and E. coll in a
J. den Hartigh. et at.1732 Patient with RA Treated with a Recombinant
Partner Participation in Cognitive-Behavioral Self- Determination of Anti-Cyclic Citrullinated Peptide Human IL-1 Receptor Antagonist (Anakinra)
Management Group Treatment for Patients with RA Antibodies in the Sera of Patients with JIA C. Turesson. K. Riesbeck.1876
W. van Lankveld. T. van Helmond. G. Naring. J.M. Low, A.K. Chauhan. D A. Kietz, U. Daud.
D.J. de Rooij. F. van den Hoogen.1738 PH. Pepmueller. T.L. Moore.1829
Dyslipoproteinemia in Patients with Active RA; Cardiopulmonary Exercise Testing in JIA Notices.xii
Effects of Disease Activity, Sex, and Menopausal G Metin. L. Ozturk. O. Kasapgopur, M. Apelyan,
Status on Lipid Profiles W-H. Yoo .1746 N. Arisoy.1834
VOLUME 31: NO. 10 OCTOBER 2004
I Editorial Adverse Events with DMARD: A Cohort Study of Leukocytoclastic Vasculitis Associated with TNF-a
j Leflunomide Compared with Other DMARD Blocking Agents
Power of the Database; An International Approach G.W. Cannon. W.L Holden, j. Juhaeri. W. Dai. N. Mohan, E.T. Edwards. T.R. Cupps, etal. .... 1955
to Studying Longterm Rheumatoid Arthritis L. Scarazzini. P. Slang.1906 Analysis of CARD15 Polymorphisms in Korean
Therapy M.N. Lassere. K.R. Johnson.1877 Infusion-Related Reactions to Infliximab in Patients Patients with AS Reveals Absence of Common
The Evolving Use of Tumor Necrosis Factor with RA in a Clinical Practice Setting: Relationship Variants Seen in Western Populations
Inhibitors in Rheumatoid Arthritis to Dose, Antihistamine Pretreatment, and Infusion T-H. Kim. P. Rahman, J-B. Jun, etal.1959
A. Kavanaugh, S. Cohen, J.J. Cush.1881 Number CDS-f T Cells Oligoclonalty Expanded in Synovial
Tumor Necrosis Factor-a Blockade and the M. J. Wasserman. D A. Weber, J.A. Guthrie, Fluid at Onset of SpA Selectively Proliferate in
Risk of Vasculitis V.P Bykerk, P. Lee, E C. Keystone.1912 Response to Self-Antigens: Characterization of
L. Guillevin, L. Mouthon.1885 Multisegment Foot Motion During Gait: Proof of Cell Specificities in Nonclonal Populations
Mechanisms of Action of Tumor Necrosis Factor Concept in RA J. Woodburn, K.M. Nelson. M.A. Trevino, E. Teixeiro. R. Bragado.1962
Antagonists and Granulomatous Infections K. Lehmann Siegel. TM. Kepple. L.H. Gerber . . 1918 Doxycycline versus Doxycycline and Rifampin in
D. Beenhouwer, R. Wallis, M. Broder, D.E. Furst 1888 Occupational Risk Factors for the Development of UChn/daimffeyrdetnat-iIantdeudc SepdA A, rwthirtiht isS.p Ae cPiarol sRpeefcetrievnec, e to
Topical Nonsteroidal Antiinflammatory Drugs SLE G.S. Cooper, C.G. Parks. E.L. Treadwell, Randomized 9-Month Comparison
Are Effective in Osteoarthritis of the Knee E.W. St. Clair. G.S. Gilkeson. M.A. Dooley_1928 J.D. Carter, J. Valeriano, F.B. Vasey.1973
R.A. Moore.1893 The Systemic Lupus Activity Measure-Revised, the Clinical Vertebral Fractures in Patients with AS
Mexican SLE Disease Activity Index (SLEDAI), and D. Vosse. E. Feldtkeller, J. Erlendsson. P. Geusens.
Articles a Modified SLEDAI-2K Are Adequate Instruments to S. vender Linden.1981
Measure Disease Activity in SLE
Fatigue Assessments in RA: Comparative A.G. Uribe, L.M. Vila, G. McGwinJr, M L Sanchez, Increasing Mineral Density Alter Menopause in
« PFFae.tr ifWgouromelf eQa.nucees toifo nVnisauirael sA inna 7lo7g6 0S Pcaalteiesn atns d Long1e8r 96 HDJiy.gDshf. uPRnrecevtvieoailnllee in, ncG eE. Sao.rf l AyR lSaigrychsott neV.meni1ct rSiccullea9rro Ssiyss 3tolic 4 IIEnnJfdc.f iieRvdcieetdsneu vtoa eDfl. BLeRgou. edmAnybbe Carraaroh tVimavmeepr .o tDeJs.bii strWieaoaenas l aetaos:nn A,ad LPMD. iiRlaeoruttk seSsret ulflod. ry for the
Can Gold Therapy Be Used More Safely in RA? C. Meune, Y Allanore. J-Y Devaux, et al.1941 B. Wardley-Smith. A. Mitchell.1986
Adverse Drug Reactions Are More Likely in Patients Autocrine Activation by IL-1a Induces the Are There Differences Between Men and Women
with Nodular Disease, Independent of HLA-DR3 Fibrogenic Phenotype of SSc Fibroblasts Prescribed Bisphosphonate Therapy in Canadian
Status Y. Kawaguchi, S.A. McCarthy. S.C. Watkins. Subspecialty Osteoporosis Practices?
P. Shah, S.M Griffith, M.F Shadforth. eta! .... 1903 TM. Wright.1946 A M. Sawka, J.D. Adachi, A. Papaioannou. etal. 1993
Conleni htde.x to Volume 31 2579
Comparing the AUSCAN OA Hand Index, Michigan Pediatric Rheumatology Alpha,-Antitrypsin Replacement Therapy Controls
Hand Outcomes Questionnaire, and Sequential FM Symptoms in 2 Patients with PI ZZ Alpha,-
Occupational Dexterity Assessment for Patients Cytokine Flexibility of Early and Differentiated Antitrypsin Deficiency
with RA Memory T Helper Cells in JIA I. Blanco, H. Canto, FJ de Serres,
N. Massy-Westropp, J. Knshnan, M. Ahem . . 1996 S. Chiesa. I. Prigione. F. Morandi, etal.2048 E. Femandez-Bustillo. M.C. Rodriguez.2082
Equivalence Study of a Topical Diclofenac Solution Prolonged Efficacy of Etanercept in Refractory
(Pennsaid*) Compared with Oral Diclofenac in Enthesitis-Related Arthritis Images in Rheumatology
Symptomatic Treatment of OA of the Knee: M. Henrickson, A. Reiff.2055
AP R.Sa. nTduogmwiezlle, dG C.Ao. nWtroellllse, dJ .TZr. iaSlh ainhouse.2002 aPnodly tmheo rRpehgisumlast oirny t hRee gPiroonm ooft eMr CRPe-1g ioAnm oofn Rg ANTES B(SGoc.nlWeer .HoRd.e esCrohmropayt),i oSn. Ainl- ESmysatdeim, Pi.c LSecel.erosis 2086
Osteoarthritic Mice Exhibit Enhanced PGE, and Chinese Children with SLE
Unchanged CGRP Release in a Novel Isolated C-H. Liao, T-C. Yao, H-T. Chung, L-C See. Autoamputation in a Patient with Cryoglobulinemia
Knee Joint Model M-L Kuo, J-L Huang.2062 S.D. Overton, J.J. Hong, T.L. Moore,
B. Averbeck, K. Rudolph!. M. Michaells.2013 Favorable Outcome in Patients with Renal F. E. Johnson.2088
Tenascin-C Concentration in Synovial Fluid Involvement Complicating Macrophage Activation
Correlates with Radiographic Progression Syndrome in Systemic Onset JRA
of Knee OA A.Y. Ramanan, N.D. Rosenblum. B M. Feldman. Correspondence
M. Hasegawa, H. Hirata, A. Sudo, el al.2021 R.M. Laxer, R. Schneider .2068
IAnBmf.lWaomn.Jg.mH Oa. tPloderenyrn MiAnxda,ur kHlte.s rA sw baibtnahds ,K PWnh.e yAes mOicbAarl o sFiuusn, cetitoanl .. 2027 AOEfnnftesaecgtti ovJnRei AsUt sAJe. nWoaf.k tiVhnerea rRb isnek cyTo hAme.Jbr.ai npWaynh Ritt eeIL.s-i1s tRanetc eSpytsot re2 m07i1c RInMahy.iAnb.ai tGuodros’ns zC Pa. lheGezan-rGocmiaay-e.Pnoorrnu aa,n Cd . SCearonteodnoi nM Rareguapritha2okse0, 90
The Prevalence of Diffuse Idiopathic Skeletal Reply E. Malsuura, A. Ohia, R. Sherriff-Tadano. . 2090
Hyperostosis in Korea Case Reports Erectile Dysfunction and Scleroderma
S-K Kim. B-R. Choi. C-G. Kim. etal. 2032 S.R. Johnson, C. Dewar. 2091
Vasculitis Associated with the Use of Leflunomide
Interrelations Between FM, Thyroid Autoantibodies, J. MacDonald, T. Zhong, A. Lazarescu, B.S. Gan, Reply J. Pope, J. Ouimel.2091
and Depression L.S. Ribeiro, FA. Proietti .2036 M. Harth.2076
Workshop Report: Clinical Diagnosis and Imaging Sensory Neuropathy Revealing Necrotizing Notices.vii
of Sacroiliitis, Innsbruck, Austria, October 9, 2003 Vasculitis During Infliximab Therapy for RA
A. Klauser, M. Bollow, A. Calin, el al 2041 P. Richette, P Dieude, J. Damiano, etal. 2079
VOLUME 31: NO. 11 NOVEMBER 2004
Editorials Polyarteritis Nodosa Reports to the Vaccine Pediatric Rheumatology
Adverse Event Reporting System (VAERS):
The Pathogenesis of Neuropsychiatric Implications for Assessment of Suspected Vaccine- HLA and Susceptibility to JIA: A Study of Affected
AM Daniisfeeasstaet iionn Sse ianr cShy sotfe mAuict oLaunptiubso dEireyst,h oerm atosus; PMro.vCo. kSende lVlera,s cRu.lPit iWs isEeM, R. . BBeaglile.r, C.A. Langford,2 181 SHib pSaaiirlsa ,i nJ . aPni tIksaonliaetmeid, JF. inTnuiosmh ilPeohtpou, lealt iaoln . . 2281
Autoantodies in Search of a Disease? Etanercept Does Not Essentially Increase the Total
J-L. Seneca!, Y. Raymond.2093 Proinflammatory Cytokine Profiles in Sera and Costs of Treatment of Refractory JIA J. Haapasaari,
Anticardiolipin Test and the Antiphospholipid Pathological Tissues of Patients with Active H.J. Kautiainen, H.A. Isomaki, M. Hakala .2286
(HE.u Ngh. eHsa) rSrisy,n Mdr. oKmhea:m 2a0s hYtae.ars and Counting! 2099 UDn-tYre. aCtehden A, OJ-SLD. L an, F-J. Lin. T-Y. Hsieh.2189 PSreelleicmt iCnaartye gCorriiteesri ao ff oJIrA C linical Remission for
Nonhuman Primate Seronegative Arthritis: Longterm Course of Mixed Cryoglobulinemia in C.A. Wallace, N. Ruperto, E.H. Giannini, etal . . 2290
Probabiiity Values for Valuable Science in a Case Patients Infected with Hepatitis C Virus Incidence of Vasculitis in Children in the Czech
Report K PH. Pritzker.2102 D. Sene, P. Ghillani-Dalbin, V. Thibaull, et al ... 2199 Republic; 2-Year Prospective Epidemiology
CRoesnetianruchou tso PCalisnsiicvael AMpoptiloicna: tFiornosm RO.Bri.g iSnaaitlieorn .t o2 104 AMsesaessusrmemenetn to fS ythsete 3m-D inim Menesaisounrainl gF aRsatrnagke of SDu. rvNeeym coP.v aD, oJl.e zHaolozvaa., P. Telekesova, 2295
Motion in AS Case Reports
Articles K. Jordan, K.L. Haywood, K. Dziedzic, etal ... 2207
WRengtIu Ilantdiounci banled S Migincarolisnagt ePllaitteh wSatryu cPtruortee iinn- 3A rthritis QIEnnuctarhneetaisstiaests io vifen t hCBeyo tnHoecu hTmeuamrnni ocCavole rrEa acvtoi dathecenro cAme cifraoolrm LLiiaoglc aaml ent CSKeormLo.nm Heogynrai tcAihv,s epT Ae-Hcr.tt shK roiimfti .sH Uu.m Paany naen,d e Ptarilm.ate 2300
H. Cheon, D.L. Boyle, G.S. Firestein.2106 A. Chambler, S. Rawlinson, R. Emery. Staphylococcal Endocarditis and Multiple
Fatigue, RA, and Anti-TNF Therapy: An A. Pitsillides.2216 ECm-bHo. lLi iiano ,a TP-Cat. ieYnato ,w Hit-hT . SCLhEu ng, R-t. Lien,
Investigation in 24,831 Patients Prevalence of the Spondyloarthritides in Patients J-L. Huang.2305
F. Wolfe. K. Michaud, T Pincus.2115 with Uveitis Pregnancy Outcome in Patients with AOSD
Efficacy and Safety of Wiliow Bark Extract in the R. Linder, A. Hoffmann, R. Brunner.2226 M. Y Mok, Y. Lo, P.Y. Leung, C.S. Lau.2307
Treatment of OA and RA: Results of 2 Randomized Analysis of 6 Genetic Loci for Disease
Double-Blind Controlled Trials Susceptibility in PsA Correspondence
C. Biegert, I. Wagner, R. Ludtke, etal.2121 G-M. Alenius, C. Friberg, S. Nilsson. J. Wahlstrom, Low Sensitivity if Anti-a-Fodrin Antibodies in
Effects of Prosorba* Column Apheresis in Patients S. Rantapaa Dahlqvist, L. Samuelsson.2230 Patients with Primary SS
with Chronic Refractory RA S. Roth.2131 Evaluation of BMD, Hormones, Biochemical N. Bizzaro, D. Villalta, E. Tonutti.2310
Thoracic Surgical Procedures in Patients with RA Markers of Bone Metabolism, and Osteoprotegerin Reply T. Witte. T. Matthias, M. Oppermann,
S.M. Caples, J.P. Utz, M S. Allen, J.H. Ryu_2136 Serum Levels in Patients with AS K. Helmke, H.H. Peter. R E. Schmidt.2311
H. Franck, T. Meurer, L.C. Hofbauer.2236 Economic Cost and Epidemiological
ACeultlo Nimumcleuanre ARnetisgpeonn Mseu tloti pPrrooteteinin Cs oomf Pprloexliefes riant ing Ultrasonographic Study of Achilles Tendon and Characteristics of FM J. Quintner, M. Cohen ... 2311
Patients with CTD Plantar Fascia in Chondrocalcinosis Reply PL. Dobkin.2311
K. Kaneda, Y. Takasaki, K. Takeuchi, etal.2142 P. Falsetti, B. Frediani, C. Acciai, etal.2242 The Treatment of Enthesitls in PsA
Association of Reduced CD4 T Celi Responses Efficacy of Continuous Passive Motion Following N. Kumar, L.J. Kay. D.J. Walker.2311
Specific to Varicella Zoster Virus with High Total Knee Arthroplasty: A Metaanalysis Reply I.E. van der Horst-Bruinsma.2311
Incidence of Herpes Zoster in Patients with SLE L. Brosseau, S. Milne, G. Wells, etal . 2251
H-B. Park, K-C. Kim, J-H Park, etal.2151 Intraarticular Corticosteroid Injection: Pain Relief in Letter
NCLlei. nuFircooauplg sSyericgeh,n iJiaf.t ircDiacon uEcgevl eaJsn..Gt sK. .i HnT aShnLloymE, :pG As otMntr.cibCuutridoyn, an2d 156 OCCRAao.n so tTEofu catvhrhhleoya g nHD.d iCripai.?t gi OsnB lo.Rs ssKeiosdun lua,l ecnSned.b AeRMrcgeaus, nctReha .g. CRehm2uenesents tP2s ooafni n, 65 MMMSRua. Ics Gcarolunepid shF, ’auJ’gP-nPi ccM.t iMMRo naySl olpDefiea,i cssJctc-rlFiooi.t ssiPsce e oNlplioys s AiIenbrv,n eeosrttmaigla.alittiyo nins o2f 313
Ewnitdho SthLeEli al NOS Gene Polymorphism Is Associated AJd. Fmirseseisotnons?, Z. Kanm, K. Lindsay, A. Gough . . . 2269 Book Review
N.C. Serrano, C. Paez, PA. Correa. J-M. Anaya 2163 Physiological Risk Factors for Fails in Older People Rheumatology, 3rd edition.2315
PNa.tZi.e nWtsa rwneitrh, EA.Ln.t iGborediideisn gtoer .Both PmScI and ds2D1N6A9 wDit hL . LSotwurenri eLkism, bA .A Trtihedrietmisa nn, K. Chapman, Correction
Immunoglobulin KM and GM Gene Polymorphisms B. Munro, S.M Murray, S.R. Lord.2272 Window of Opportunity [editorial] D.E. Furs! . 2315
Modify the Clinical Presentation of Primary SS In Memory: Dr. T. Douglas Kinsella
M. Pertovaara, M. Hurme, J. Antonen, A. Pasternack, M. J. FriUler. 2280 Notices.V
J.P. Pandey.2175
25H0 The Journal of Rheumatology 2004; 31:12